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Abstract 
Firmly established as a model organism for embryonic developmental studies, zebrafish 
is now emerging as an effective system to elucidate the fundamental aspects of several 
human diseases. Despite the significant evolutionary distance, gene functions and 
pathways are often highly conserved between zebrafish and humans. Previous work has 
identified nonsense mutations, associated with hearing deficiency, in the small muscle 
protein, X-linked (SMPX) gene and a loss-of-function mechanism underlying this form of 
impairment has been proposed. SMPX encodes a cytoskeleton-associated protein that 
has been suggested being responsive to mechanical stress. The presence of Smpx in hair 
cells of the murine cochlea reinforces the thesis of its importance in ear functioning. 
In this study we first provided an overview of the expression of smpx during zebrafish 
embryonic development. We showed that from the 4-somite stage, zebrafish smpx was 
first expressed in the ciliated organ Kupffer’s vesicle (KV), responsible for the left-right 
organs asymmetry, and then, as in mammals, expressed in the heart and in the inner 
ear, among other territories. Knock-down of smpx in zebrafish embryos resulted in the 
reduced number of cilia in KV and, consequently, the left-right patterning of internal 
organs resulted compromised, mimicking human heterotaxy, a disorder of laterality. 
Moreover, smpx knock-down resulted in the marked decrease of the number of cilia in 
the ear macular regions, providing a possible explanation for the hearing loss in SMPX-
mutated patients.  
In conclusion, this study contributes to the comprehension of the link between SMPX and 
human hearing loss, delivers a novel heterotaxy-candidate gene, and finally provides a 
robust animal tool for the future elucidation of the mechanisms behind both 
deafness/hearing loss and heterotaxy. 
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State of the art 
Cilia and ciliopathies  
Cilia are antenna-like membrane-associated structures playing essential roles during 
development, as well as during the normal function of many cells throughout the 
embryo and adult body. Although these highly conserved structures are found across a 
broad range of species, a nearly ubiquitous appearance is observed only in vertebrates. 
Cilia can be structurally divided into sub-compartments (Fig. 1): (i) a basal body, that 
consists of nine triplets of microtubules arranged in a ring from which extend three 
microtubules; (ii) a transition zone, region from which a nascent cilium grows; (iii) the 
middle zone, composed of nine doublets consisting of just A and B filaments, and finally 
(iv) the axoneme, that terminates with the distal zone, comprised primarily of 
microtubule singlets. Most cell types assemble only one cilium (a monocilium or primary 
cilium), whereas some cells build cilia bundles that consist of 200-300 individual 
organelles (multiple cilia) (Fliegauf et al., 2007). The formation of cilia comprises 
targeting of specific proteins to the basal body area where pre-assembly of axonemal 
substructure (such as outer dynein arms) occurs. The transport of proteins and 
multiprotein precursors across the ciliary compartment border and along the length of 
the axonemes to their functional assembly site is dependent on intraflagellar transport 
(IFT). Protein are loaded onto the IFT particles at the ciliary base within the cytoplasm 
and transferred across the ciliary compartment border in a process known as 
compartmentalized ciliogenesis.  
Cilia can either be motile or immotile. The 9+2 axonemes of most motile cilia are 
assembled by nine peripheral doublet microtubules surrounding two central 
microtubules (central pair complex); 9+2 axonemes contain associated structures 
including inner and outer dynein arms, radial spokes and nexin links. The 9+0 axonemes, 
which are found in most non-motile cilia, lack of the two central microtubules and are 
devoid of dynein arms. Mutations in genes encoding proteins that participate in IFT 
cause ciliogenesis defects of both motile and immotile cilia. 
Although there are many different classes of cilia with a diversity of variation, all cilia 
types share the basic structural units composed of the outer microtubules doublets and 
the ciliary membrane. Even though the basic structure of the different types of cilia is 
obviously similar, they exert various tissue-specific functions during development, tissue 
morphogenesis and homeostasis (Fliegauf et al., 2007). 
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Defective and dysfunctional functioning in motile and non-motile cilia affects multiple 
systems, causing blindness, deafness, chronic respiratory infections, kidney 
disease, heart disease, infertility, obesity and diabetes.  These symptoms have 
significant impact on those affected; some are devastating, most are life-threatening. 
These so-called “ciliopathies” are usually genetically inherited, and at present there are 
few, if any cures. 
 
Zebrafish models of ciliopathies 
Zebrafish have emerged as useful organisms in which to explore the consequences of 
ciliary dysfunction and to model human ciliopathies. Zebrafish ciliary models with 
defects in various genes often display similar phenotypes of human ciliopathies. 
Cilia dysfunction and defects during the embryonic establishment of left-right axis, for 
example, can lead to heterotaxy, the randomization of the left-right body asymmetry, 
possibly leading to malformation of the organs asymmetric along the left-right axis. 
Heterotaxy is tipically associated with heart malformations and anomalies of the visceral 
organs, as well as loss of normal organs asymmetry (Sutherland and Ware, 2009). It has 
been observed that half of individuals with primary ciliary dyskinesia (PCD) exhibit situs 
inversus totalis (also referred to as Kartagener’s syndrome). A similar phenotype was 
observed in mice with recessive mutations in Lrd, the ortholog of DNAH11, a human 
axonemal dynein β-chain gene. During early embryonic development (~7.5 days 
postcoitum), the rotational movement of nodal cilia at the ventral pole of the murine 
embryo creates a leftward fluid flow (nodal flow) that is thought to induce body 
Figure 1. Ciliary sub-compartments (Modified from Fliegauf et al., 2007).  
State of the art 
 
 5 
symmetry breaking. Indeed, an artificially generated nodal flow independent from 
ciliary motility was found to be sufficient to determine laterality. Similar laterality 
breaking mechanisms, involving the Kupffer’s vesicle (KV), have also been proposed for 
zebrafish (Fliegauf et al., 2007).  
In zebrafish, the KV is a transient spherical organ (Fig. 2) which originates from a group 
of approximately two-dozen cells, known as dorsal forerunner cells (DFCs); DFCs migrate 
at the leading edge of the embryonic shield (the zebrafish equivalent of the mouse 
node) during gastrulation. In contrast to other cells in this region, DFCs do not involute 
during gastrulation, but remain at the leading edge of epibolic movements. At the end 
of gastrulation, DFCs migrate deep into the embryo and organize to form KV. During 
subsequent somite stages, KV localizes ventrally to the forming notochord in the tailbud 
and adjacent to the yolk cell. It is now composed of two layers of cells having the cilia 
at both the dorsal roof and the ventral floor; all these cells possess monocilia (Essner et 
al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
A combination of laser ablations of DFCs which perturbs KV morphogenesis, 
embryological manipulations, analyses of mutants and antisense morpholinos against 
zebrafish left-right dynein-related1 (lrdr1) injected either into all embryonic cells or 
specifically targeted to KV precursors, demonstrates that ciliated KV cells control LR 
development in different organs like, for instance, brain, heart, and gut (Essner et al., 
2005).  
An example of human ciliopathies for which there is a zebrafish model is the Usher 
syndrome (USH). USH is the most frequent cause of deaf-blindness; it is a heterogeneous 
disease associated, in rare cases, with bronchiectasis, chronic sinusitis, and reduced 
Fig. 2. Kupffer’s vesicle is a ciliated organ in zebrafish. During somite stages of zebrafish 
development, Kupffer’s vesicle (KV) forms in the tail region (A). Fluorescent immunostaining of 
KV cells (B) with atypical protein kinase C antibodies (red) to mark epithelial cells and acetylated 
tubulin antibodies (green) to label cilia. Each KV cell has a single cilium (www.amacklab.org). 
State of the art 
 
 6 
nasal mucociliary clearance, indicative of ciliary dyskinesia. It is characterized by retinal 
degeneration, due to progressive loss of photoreceptors, and congenital deafness. The 
relevant USH proteins possibly function in sterocilia as well as in photoreceptor cilia 
(Fliegauf et al., 2007). Although at least fourteen different chromosomal loci have been 
linked to USH, only eleven of the genes have been identified to date. Initially studies 
were concentrated on the Usher 1C gene (USH1C), which encodes a protein that has 
been proposed to function as a key scaffolding molecule to which most other Usher 
proteins can bind. Patients with mutations in USH1C exhibit a severe Usher pathology 
with profound congenital hearing impairment, vestibular dysfunction, and clinically 
appreciable retinal degeneration in childhood or early adolescence. Mouse models of 
USH1C, with mutations in the mouse Ush1c gene, exhibit profound deafness but fail to 
show notable retinal defects. Recent studies developed two zebrafish models for USH1C, 
both of which exhibit a strong deaf-blindness phenotype at early developmental stages. 
Young fish with depleted ush1c function have penetrant and specific visual defects as 
well as compromised hair cell development resulting in hearing and balance impairment 
(Phillips et al., 2011). 
 
Non-Syndromic Hearing Loss (NSHL) 
As the most common sensory disorder in humans, hearing loss affects about 1 in 1000 
newborns. It is assumed that at least half of the cases have a genetic basis, and more 
than two-thirds of this subset is classified as non-syndromic hearing loss (NSHL) because 
of the absence of additional symptoms. The vast majority of NSHL is caused by 
mutations in autosomal genes, while X-chromosomal inheritance accounts for only 1–5% 
of the cases (Huebner et al., 2011). In this latter case, females often show later onset 
and less severe presentation than males thanks to random X-inactivation. Currently, 
there are five known chromosomal NSHL loci for X-linked deafness: DFNX1 MIM# 304500, 
DFNX2 MIM# 304400, DFNX3 MIM# 300030, DFNX4 MIM# 300066, and DFNX5 MIM# 300614 
(Abdelfatah et al., 2013). DFNX can be either pre- or post-lingual, with an age of onset 
varying from congenital (DFNX1, DFNX2, and DFNX3), to childhood (DFNX4), or 
adolescence (DFNX5). The type of hearing impairment is sensorineural, except for 
DFNX2, that shows mixed hearing impairment, and DFNX5, which is accompanied by poor 
speech discrimination scores and poor understanding. In most patients hearing 
impairment is progressive and severely affecting all frequencies (Schraders et al., 2011). 
Three papers were recently published which identified SMPX (Small Muscle Protein X-
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Figure 3. SMPX gene structure and identified NSHL-linked mutations (Modified from Abdelfatah et al. 2013). 
linked) as the deafness-causative gene at the DFNX4 locus in two Dutch families 
(Schraders et al., 2011), one German family, one Spanish family (Huebner et al., 2011), 
and two families of the Newfoundland island (Abdelfatah et al., 2013). 
 
Human and mouse Smpx Gene 
The human SMPX gene, originally cloned from skeletal muscle, encodes an 88-amino acid 
protein with no known functional domains (Patzak et al., 1999). SMPX was also 
identified in a screening for stretch-responsive skeletal muscle genes and shown to be 
highly upregulated in response to passive stretch in vivo (Kemp et al., 2001). The gene 
consists of five exons (≥172, 57, 84, 148, ≥422 bp) and four introns (3639, 10410, 6052, 
31134 bp), comprising together a 52.1 kb genomic region (Patzak et al., 1999). SMPX is 
proline-rich and contain a potential nuclear localization signal, two casein kinase II 
phosphorylation sites (CKII), and a destabilizing sequence proline-, glutamic acid-, 
serine-, threonine-rich (PEST), that suggests SMPX undergoes rapid degradation 
(Schraders et al., 2011).  
As mentioned above, in four different family four nonsense mutations have been 
identified. A first paper showed like in a German family, sequence analysis revealed a 
p.Glu37X mutation (c.109G>T), while sequencing of the SMPX gene in a Spanish family 
disclosed a p.Gly59X mutation (c.175G>T) (Huebner et al., 2011). Concurrently, a study 
of two additional families identified a large Dutch family with a p.Glu72X (c.214G>T) 
and a second one which had a single base pair deletion (c.130delG, Schraders et al., 
2011). At last, in two family of Newfoundland island, a novel same point deletion 
(c.99delC) has been found (Abdelfatah et al., 2013) (Fig. 3). 
  
  
  
The phenotype of all the SMPX mutations carriers is similar; it is also interesting to note 
that all the mutations associated with SMPX and related to hearing loss are null 
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Figure 4. Relative SMPX mRNA expression as determined by quantitative PCR in fetal (A) and adult (B) human 
tissues (Modified from Schraders et al., 2011). 
  
mutations resulting in a premature stop codon. This molecular feature suggests that the 
mutant transcripts may undergo nonsense-mediated mRNA decay (NMD), suggesting loss-
of-function as the underlying mechanism of the hearing impairment, although further 
studies are needed to confirm it. Nonetheless, all these data support the association of 
SMPX to the DFNX4 locus (Abdelfatah et al., 2013). 
The first study of the expression pattern of SMPX was performed with human multiple 
tissue RNA blot and showed that SMPX was abundantly and specifically expressed in 
skeletal and heart muscle (Patzak et al., 1999). Subsequently, since the identification of 
mutations in SMPX as a possible cause of non-syndromic hearing impairment, additional 
RT-PCR assays were performed. Results, in agreement with previous studies, confirmed 
the presence of abundant SMPX transcription in both fetal and adult skeletal muscle and 
heart and, in addition, showed relatively high SMPX transcripts levels in fetal inner ears 
(Fig. 4), supporting the involvement of SMPX in X-linked NSHL (Schraders et al., 2011).  
As a first step to identify a function of this gene, additional studies have been 
performed using murine models. 
 
  
  
The murine Smpx gene encodes an 85-amino acid protein, which is associated with actin 
and focal adhesion complexes and functions as a regulator of cytoskeletal dynamics 
(Kemp et al., 2001; Schindeler et al., 2005). Smpx displays 85% of identity with the 
human protein and, unlike SMPX, the gene consists of six exons and five introns 
comprising together 53,62 kb. Despite two amino acids that differ between the murine 
and the human proteins, the CKII consensus sequence is still maintained, supporting its 
candidature as a genuine site for phosphorylation. Indeed, it has been hypothesized that 
phosphorylation of Smpx may regulate its function and subcellular localization (Kemp et 
al., 2001).  
(A) (B) 
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Figure 5. Smpx (Chisel Csl) mRNA expression. (A) RNase protection analysis of Smpx and control cyclophilin (Cyclo) 
mRNAs in adult mouse tissues. (B–K) Whole-mount in situ hybridization using Smpx probe on mouse embryos. (B) Ventral 
view of E8.25 embryo. (C) Section of the embryo shown in B. Arrows indicate expression on the ventral surface of the 
fusing heart tube. (D) Ventral view of E8.5 em- bryo. (E) Section of embryo depicted in D showing Smpx expression at the 
outer curvature of the ventricles. (F–H) E10.5 embryo viewed from the ventral and left and right sides, respectively. Arrow 
in F indicates rib of expression in outflow tract. Arrow in G indicates expression in presumptive left atrial appendage. (I) 
Section of E10.5 heart. (J) E9.5 Nkx2-5-/- embryos (-/-) compared with wild-type sibling (+/+). (K) E13.5 embryos 
comparing expression of Smpx and myogenin. as, atrial septum; at, atrium; avc, atrioventricular canal; lv, left ventricle; oft, 
outflow tract; rs, right sinus horn; rv, right ventricle; tb, trabeculae (Yoon et al., 2011).  
At first, RNase protection analysis of mRNA samples extracted from a variety of adult 
mouse tissues showed a strong signal of Smpx (also called Chisel, Csl) in heart, skeletal 
muscle, and tongue (Fig. 5A), with a weaker signal in lung, testes, and large intestine 
(Palmer et al., 2001). Also interestingly, the presence of Smpx expression was detected 
in various developing organs at different embryonic stages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In-situ hybridization assays, performed on mouse embryos, showed that Smpx starts to 
be expressed from E8.25 in those myocytes, located at the ventral surface of the heart 
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progenitor region, undergoing active fusion (Fig. 5B,C). The transcript was present 
during the early stages of heart looping (E8-E8.5), restricted to the myocardial layer at 
the outer curvature of the presumptive left and right ventricles (Fig. 5D,E). By E9.5–
10.5, the expression was also evident in the developing sinoatrial region in a left–right 
asymmetric pattern. On the right side, the developing right atrium and right horn of the 
sinus venosus were strongly positive, whereas on the left a disc-shaped pattern was 
evident in the dorsolateral region of the common atrium, suggestive of the future 
position of the left atrial appendage. However, the left sinus horn was negative for 
Smpx expression. Transcripts were undetectable in most of the atrioventricular canal, 
the inner curvature, and in myocardium associated with the forming atrial septum (Fig. 
5,G,I). The outflow tract was also negative, except for a unique rib of expression along 
its outer curvature (Fig. 5F). During fetal development, Smpx expression continued in 
the outer curvature of the ventricles and in the atrial appendages (Palmer et al., 2001). 
Moreover, also in developing skeletal muscles starting from E11.5 (specifically at E13.5), 
it is evident the expression of Smpx in the myotomal compartment of somites and in 
developing limb, head, and neck muscles in a pattern resembling that of the myogenic 
regulatory factor gene myogenin (Fig. 5K) (Palmer et al., 2001).  
An interesting study identified Smpx between novel genes associated with hair cell 
differentiation or hearing loss during the inner ear development (Fig. 6); an archived 
gene expression dataset generated using mouse inner ear tissues at several embryonic 
stages has been analyzed (Yoon et al., 2011). By hybridization assays, Smpx activity was 
compared with the cochlear expression patterns of Atho1 (Atonal homolog, also known 
as Math1) and Myo15 (myosin15), two well known markers for hair cells, both of which 
are essential for their differentiation and maturation. Data showed that Smpx is 
expressed in the hair cells of the vestibular organs including utricule, saccule and all the 
cristae at E15.5, at least up to postnatal stages P5 (Yoon et al., 2011). In detail, Smpx 
expression was initially barely detectable at the cochlea level, probably because 
differentiation of the cochlear hair cells occurs later than the vestibular hair cells. At P1 
stage, Smpx transcript was clearly visible in the base and mid-base of the cochlear duct 
and faintly in the mid apex. By P5 Smpx was strongly expressed in the hair cells of all 
cochlear turns region (Yoon et al., 2011). So, since the onset of Smpx expression in the 
developing hair cells appeared to be slightly delayed in comparison to Myo15, the 
authors suggested a possible role of Smpx in maturation or maintenance, rather than 
early specification of hair cells. 
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Immunolocalization studies conducted on the adult mouse cochlea revealed the 
presence of the protein in different cell types, both in the sensory epithelium (inner and 
outer hair cells) and non-sensory supporting cells (Deiter cells, Bötcher cell, and inner 
and outer pillar cells), as well as in Root cells, involved in building up a cellular network 
Figure 6. Diagrammatic representation of the substructures of the mouse inner ear and expression patterns of 
Smpx in the developing inner ear. (A) mouse inner ear schematic representation. (a-h) Expression patterns of Smpx in 
the developing inner ear analyzed with in situ hybridization at E15.5 (a- d), P1 (e-g), and P5 (h, i). Lines in the inner ear 
diagram show the levels of sections. Atoh1 (a, e) and Myo15 (b, f ), well known markers for hair cells, were used to locate 
the hair cells in the inner ear tissues. At E15.5, expression of Smpx was found in the developing hair cells of the vestibular 
organs (c). At P1, Atoh1 expression was found in the hair cells of all cochlear turns (e, arrows) and Myo15 expression was 
found in the base, mid-base, and mid-apex of the cochlea (f, arrows), but not yet in the apex (f, asterisk). Smpx expression 
was found in hair cells of basal and mid-basal turns (g, arrows) and weakly in the mid-apical turn (g, arrowhead). At P5, 
Smpx expression was detected in hair cells of all cochlear turns (h, i, arrows) (Modified from Yoon et al., 2011). 
  
A 
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in the lateral wall of the cochlea (Huebner et al., 2011). Given the association of SMPX 
with the cytoskeleton, its responsiveness to mechanical force, and the detection of 
Smpx in hair cells in the mouse, Huebner and colleagues speculated that SMPX might 
play a role in the maintenance of stereocilia, which are permanently exposed to physical 
stress (Huebner et al., 2011).   
A second link between Smpx and cochlea development and function is provided by IGF-1 
(insulin-like growth factor 1). When Smpx is in-vitro stimulated by IGF-1, it modifies cell 
shape and promotes myocyte fusion in C2C12 mouse myogenic cells. IGF-1 mutations in 
humans are associated with syndromic sensorineural deafness and Igf-1-deficient mice 
have multiple cochlear abnormalities, including anomalous differentiation, reduced 
survival of spiral ganglia neurons, and abnormal tectorial membrane. Moreover, MEF2 
(myocyte enhancer binding factor 2) has been indicated to be a target gene of IGF-1 in 
the mouse cochlea in both the sensory cells and the spiral ganglia neurons. Interestingly, 
the IGF-1-mediated increase of MEF2 activity in myoblasts is augmented by Smpx; 
additionally, a consensus sequence for MEF2 binding is present twice in the highly 
evolutionarily conserved 5’ upstream region of SMPX, suggestive of a more complex 
network involving these three players. 
Another remarkable in-vitro data associated with inner ear dysfunction are defects in 
the Rac1/p38 pathway, which is a target of Smpx (Schindeler et al., 2005). The small 
GTPase Rac1 is activated by biomechanical stress, upon which it is recruited to sites of 
actin reorganization and integrin-mediated cell adhesion. Intriguingly, conditional 
ablation of Rac1 in the otic epithelium of mice resulted in defective morphogenesis of 
the auditory sensory epithelium and stereociliary bundle (Wei et al., 2005). p38 kinase 
has also been shown to be of relevance for inner ear function, acting downstream of 
Smpx and Rac1 in regulating actin dynamics; interestingly, inhibition of p38 MAP kinase 
phosphorylation suspended gentamicin-induced ototoxicity, a side effect of 
aminoglycoside therapy leading to permanent hair cell loss and hearing impairment 
(Schindeler et al., 2005). 
 
Zebrafish as a model for inner ear development, function, and deafness 
Firmly established as a model organism for embryonic developmental studies, zebrafish 
is now emerging as an effective system to elucidate the fundamental aspects of several 
human diseases (Graham and Currie, 2007). Despite the significant evolutionary 
distance, gene functions and pathways are often highly conserved between zebrafish 
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Fig. 7. Zebrafish larval and adult ear. (A) Diagrammatic representation of the zebrafish larval ear. All five sensory 
patches are indicated in color. Dotted lines indicate the epithelial structures around which the semicircular canals form. 
 (B) Diagram of the adult zebrafish ear. A third macular organ, the lagena (dotted area), forms later during the juvenile 
stage. Colors correspond to those in panel A. 
Abbreviations: ac, anterior crista; am, anterior macula; l, lagena; mc, medial crista; o, otolith; pc, posterior crista; pm, 
posterior macula; s, saccule; u, utricle. (Modified from Nicolson 2005). 
and humans. Specifically, zebrafish represent an excellent model for studying inner ear 
development and function. Indeed, zebrafish ear development is quite similar to what 
observed in other vertebrates (Whitfield et al., 1996), and the signaling pathways 
required for its development and functions are strikingly conserved (Whitfield, 2002).  
The development of the ear proceeds quite rapidly in zebrafish. Within 16 hours post 
fertilization (hpf), a thickening of the ectoderm, the otic placode, becomes visible. Soon 
after cavitation (18 hpf), the first hair cells appear at the opposite poles of the ventral 
portion of the lumen. These two sensory patches will give rise to the anterior and 
posterior maculae, respectively. Around 20 hpf, when the first hair cells appear, otoliths 
(calcium carbonate stone situated above the macula) attach to the kinocilia. During this 
period neuroblasts delaminate from the otic vesicle to form the first-order neurons of 
the auditory/vestibular (VIIIth) nerve. Forces impinging upon the otoliths cause them to 
move, which in turn deflect the underlying hair bundles. Macular organs in zebrafish are 
important for both hearing and for sensing linear acceleration and gravity. At 
approximately 45 hpf, epithelial columns sprout from the otocyst wall and grow into the 
lumen, where they meet and fuse in the following 10-hour stretch. Eventually, they will 
form the central hubs around which the semicircular canals develop. The sensory 
patches, or cristae (sensory epithelium of hair cells and supporting cells inside the 
semicircular canals) will form about a day later than the anterior and posterior maculae. 
By 96 hpf, the larvae are free swimming and have fully functional ears (Fig. 7A).  
 
 
 
 
 
 
 
 
 
 
 
 
Although the zebrafish ear does not contain a specialized hearing organ - there is 
no equivalent of the mammalian cochlea - zebrafish are classified as ‘hearing 
A B 
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specialists’, being characterized by morphological adaptations (Weberian ossicles, see 
below in this text) that aid in the detection of sound pressure (Nicolson, 2005). After the 
larval stage (30 days post fertilization, dpf), zebrafish develop additional organs 
including the macular organ called lagena, and the macula neglecta, with auditory 
function (Fig. 7B). As mentioned above, zebrafish develop a series of bones known as 
Weberian ossicles, connecting the swim bladder to the saccule. Sound can set the air-
filled swim-bladder into motion, and such motion is transmitted to the sensory 
epithelium via the ossicles, thus amplifying the sound (Nicolson, 2005). 
As in other vertebrates, the inner ear is also used to maintain balance (Whitfield, 2002). 
In addition, fish like frogs possess another organ that employs sensory hair cells, the 
lateral line organ, taking its name from the clusters of hair cells, known as neuromasts, 
located in a series extending along the trunk. The lateral line organ allows the detection 
of low-frequency stimuli, such as water movements, and it is important in schooling, 
prey detection, and other behaviors (Nicolson, 2005).The anatomy of the zebrafish ear 
differs significantly from that of the human inner ear, and thus the zebrafish model 
cannot hope to recapitulate all aspects of human hearing loss (Whitfield, 2002). 
Nevertheless, as previously mentioned, it is clear that many of the same genetic 
pathways are utilized for the development and function of the inner ear in all vertebrate 
groups. Hair cells, for example, require MyosinVIIa to function correctly, whether in a 
human cochlea or a zebrafish neuromast. Likewise, FGF signaling appears to play an 
important role in otic induction in chick, mouse, and zebrafish, although different FGFs 
may be utilized for the same process in different species. As yet, there are zebrafish 
models of many human deafness syndromes including, for example, Usher syndrome, an 
autosomal recessive disorder characterized both by deafness and blindness, 
Waardenburg-Shah syndrome, a rare genetic disorder characterized by auditory-
pigmentary abnormalities, and Hirschsprung disease (Whitfield, 2002). Furthermore, 
zebrafish is amenable to genetic and molecular manipulations that are infeasible in any 
other vertebrate model, and will therefore be of importance in increasing our 
understanding of both the biology of inner ear development and, possibly, the etiology 
of human hearing loss. 
 
Zebrafish smpx 
Zebrafish smpx is located on chromosome 24 and consists of five exons and four introns 
spanning together about 27 kb. The gene encodes an 83-amino acid protein sharing 85% 
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of identity with the human protein. 
Main results 
 16 
Main results 
smpx expression analysis 
The spatial and temporal smpx expression patterns during the early stages of zebrafish 
development have been analyzed by means of RT-PCR and whole mount in-situ 
hybridization (WISH) assays. RT-PCR has been performed on developmental stages from 
1-cell stage to 72 hpf (hours post fertilization) (Fig. 8). smpx starts to be expressed from 
the 4-somite stage, with the smpx-specific primers detecting two amplicons of 188 and 
275 bp, respectively, corresponding to alternative splicing isoforms (Fig. 8B,C), as 
confirmed by DNA sequencing. The two mRNAs encode a short (54 amino acid residues) 
and a long (83 amino acid residues) form of protein (Fig. 8C). Interestingly, even though 
no Smpx short form is reported in any protein database, a more in depth bioinformatic 
inquiry revealed that such splicing event does occur also in higher vertebrates; indeed, 
the BLAST/tblastn analysis of the ncbi Expressed Sequence Tags (ESTs) database 
returned - besides some positive hits concerning Smpx short form in other fish species 
(i.e. Oncorhynchus mykiss and Salmo salar) - also positive hits regarding the presence of 
the mRNA encoding such form of the protein in the two mammals Heterocephalus glaber 
and Sus scrofa (data not shown). Later on during zebrafish development, only the 275 bp 
smpx amplicon is detectable in the stages analyzed (24 – 72 hpf).  
smpx expression at 4-somite stage has been also revealed by WISH; at this stage, smpx 
mRNA marks specifically the Kupffer’s vesicle (KV) (Fig. 9A,B). From 10 somites to 24 
hpf, smpx is expressed at the level of the somites (Fig. 9C,10). At 24 hpf the signal is 
still present in the somites and starts to be visible in the heart (Fig. 10A). By 36 hpf, 
smpx is also detectable at the ear level (Fig. 10B,C). The images at 48 hpf show smpx 
persistent expression in the heart (Fig. 10D,E) and display the specific signal in the ear, 
precisely in the hair cells of the anterior (Fig. 10F) and the posterior macula (Fig. 10G). 
At 72 hpf, smpx transcripts are visible in the heart (Fig. 10H), in the ear (Fig. 10J,K) and 
in the branchial arches (Fig. 10H). Additionally, smpx expression is now detectable in 
the developing eye muscles and in the developing pectoral fins (Fig. 10I).   
 
smpx functional analysis 
smpx functional analysis in zebrafish embryos has been performed by means of gain- and 
loss-of-function assays, microinjecting smpx synthetic mRNA and smpx-specific 
Morpholino (MO) antisense oligonucleotide, respectively. GFP in-vitro synthesized mRNA 
has been used as control for the gain-of-function assay, while a standard control MO (SC-
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MO) injection has been employed to monitor the loss-of-function analysis (from now on 
all the MO-injected embryos will be defined as morphants).  
While the gain-of-function assay did not determine any phenotypic alteration in the 
embryos at all the tested stages (data not shown), smpx functional ablation produces 
obvious embryonic defects, including abnormal body curvature, randomized heart 
looping, cardiac edema, and cysts formation (Fig. 11). Zebrafish body curvature 
alterations, as well as pronephric cysts formation and altered left-right patterning, are 
linked to defects in genes important for cilia development (Serluca et al., 2009). As 
mentioned above, the earliest visible sign of embryonic smpx expression occurs in the 
KV, where ciliated cells produce a directional flow required for the establishment of the 
left-right asymmetry in the placement of the internal organs. Therefore, in order to 
determine whether the loss of function of smpx produced any effects on KV cells, 10-
somite morphant embryos were stained with acetylated tubulin antibody for cilia 
labelling and analyzed under a confocal microscope (Fig. 12). smpx morphants displayed 
a fully formed KV, although they showed a lower number of cilia (less of 50%; n 
morphants = 8, n controls = 9) when compared to control embryos (Fig. 12A,B). These 
findings lead us to evaluate, like consequence of deficiencies in the KV, a possible loss 
of the left-right organ asymmetry. Consequently, to assess organ laterality in smpx 
morphants, we analyzed the position of the heart, liver, pancreas, and medial habenular 
subnuclei by means of WISH, employing specific markers for these organs (Fig. 13). In a 
wild-type zebrafish embryo, the ventricle of the heart loops toward the right and the 
atrium loops towards the left, the liver is positioned to the left of the midline, the 
pancreas lies to the right of the midline and the number of medial habenular subnuclei 
is greater in the right side of the dienchephalon (Fig. 13). WISH using prox1 probe 
(Pistocchi et al., 2008), labeling liver, pancreas, and medial habenular subnuclei, 
showed the wild-type pattern (see SC-MO embryos in Fig. 13E,H) in 30% of smpx 
morphants, while an undefined asymmetry (Fig. 13G) or a complete reversal in the 
placement of the organs is present in the remaining 70% of the embryos (Fig. 13F,I; n 
morphants and n controls = 100). The same results were obtained using the cardiac-
specific cmlc2 probe (Yelon et al., 1999): 37% of smpx-morphants evidenced the correct 
orientation (see SC-MO embryos in Fig. 13A), while in the remaining 63% a non-looped 
(Fig. 13C,D) or an inverted heart (Fig. 13B) was visible (n morphants = 120, n controls = 
85). Taken together, this wealth of data strongly suggests that such anomalies in the 
left-right asymmetry may represent a direct consequence of the abnormal number of 
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cilia in the KV determined by smpx down-regulation.  
In order to investigate ear development in smpx deficient embryos, the expression 
pattern of two different ear markers at two different stages of development has been 
analyzed by WISH (Fig. 14A-D), together with FITC-phalloidin staining to highlight the 
cells cytoskeleton (Fig. 14E,F). Specifically, the macular markers fgf8 (Reifers et al., 
1998) and pax5 (Kwak et al., 2006) has been employed to paint the ear of 30 and 48 hpf 
morphants, respectively (n morphants = 64 + 71, n controls = 51 + 60). The assay 
demonstrated that smpx knock-down did not exert any effects on the formation of the 
gross ear structures in all analyzed stages (Fig. 14). Indeed, the anterior macula is 
correctly formed also in smpx morphants (Fig. 14A-D), and the whole ear structure is 
indistinguishable between smpx and standard control embryos, as proved by the FITC-
phalloidin staining (Fig.14E,F). Finally, in order to assess potential effects of smpx 
down-regulation on ear cilia structure, immunohistochemistry assays using anti-
acetylated tubulin antibody have been performed. The fluorescence confocal 
microscope observation of the morphant ear revealed the noteworthy 40% reduction of 
the number of cilia in the macular regions (Fig. 15B; n morphants = 10, n controls = 11). 
Therefore, it is conceivable to presume a crucial role of smpx in the proper 
differentiation and/or maintenance of the cilia structure also in the ear, providing a 
possible explanation to the documented cases of SMPX-linked human deafness (Huebner 
et al., 2011; Schraders et al., 2011; Abdelfatah et al., 2013).  
 
 
 
Fig. 8. smpx expression profile during zebrafish development. 
(A) Zebrafish smpx accession number and sequences of the primers designed to conduct the 
expression analysis. 
(B) Ethidium bromide-stained gel of the semi-nested RT-PCR performed with the smpx_F1 and 
smpx_R1 primers using the smpx_F0/smpx_R1 reaction as template. 188 and 275 bp bands 
represent the two products of alternative splicing of the smpx RNA (see below for details). The 
gene is expressed starting from the 4-somite stage up to 72 hpf (upper panel). RT-PCR 
employing β-actin specific primers has been performed as control for RNA integrity. 
(C) smpx genomic organization and alternative splicing forms of the mRNA. Zebrafish smpx, as 
well as the human SMPX, spans five exons (ex1 - ex5) on chromosome 24, three of which (red 
boxes) encoding a polypeptide of 83 amino acid residues (long form). When intron 2 donor site 
(GT, boxed in yellow) and intron 3 acceptor site (AG, boxed in purple) interact, exon 3 is spliced 
out, resulting in a smaller transcript encoding a 54 amino acid residues protein (short form); in 
red the portion of the long form encoded by exon 3. The intron 2/exon 3 and exon 3/intron 3 
splice junctions are boxed in green. 
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Fig. 9. Developmental expression of smpx in zebrafish. 
(A, B) smpx WISH at 4-somite stage: the transcripts are detected in the KV (white arrowheads). 
(C - F) smpx WISH at 10- and 15-somite stage: the transcripts are detected in the somites (black 
arrowheads). 
(A, D, F) dorsal view. (B, C, E) lateral view. (B - F) anterior to the left. 
Scale bars indicate 150 µm.  
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Fig. 10. Developmental expression of smpx in zebrafish. 
(A) smpx WISH at 24 hpf: the transcripts are detected in the somites (black arrowhead) and are now 
also visible in the heart (red arrowhead). 
(B, C) smpx WISH at 36 hpf: the transcripts are still present in the heart (red arrowhead) and now 
label the ear (yellow arrowhead). 
(D-G) smpx WISH at 48 hpf: (D) the transcripts are present in the heart (red arrowhead) and (D, E) in 
the ear (yellow arrowhead). (E) Magnification of the heart at 48 hpf. (F, G) Magnification of the ear: (F) 
anterior macula, (G) posterior macula (pm). 
(H-K) smpx WISH at 72 hpf: (H, I) smpx transcripts are visible in the heart (red arrowhead), the ear 
(yellow arrowhead), the branchial arches (blue arrowhead), the developing eye muscles (green 
arrowheads), and the pectoral fins (pink arrowheads). (J, K) Magnification of the ear: (J) anterior 
macula, (K) posterior macula. 
(I) shows dorsal view; all the other panels show lateral views. In all panels anterior is to the left, dorsal 
to the top. 
Abbreviations: am, anterior macula; pm, posterior macula. 
Scale bars indicate 200 µm (A, D, H), 100 µm (B), 60 µm (C, E), 30 µm (F, G), 20 µm (J, K).  
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Fig. 12. Defective number of cilia in the Kupffer’s vesicle (KV) following smpx down-
regulation. Immunofluorescence performed with antibody against acetylated tubulin in 10-
somite stage embryos KV (green circles):  (A) normal control embryos (SC-MO) display a higher 
number of KV cilia in comparison to (B) smpx morphants. 
Scale bars indicate 10 µm.  
  
 
Fig. 11. smpx morphants phenotype. (A) Standard-ctrl morpholino (SC-MO) embryo at 72 hpf. 
(B, C) smpx morphant embryo exhibiting ventral axis curvature (black arrowheads), cardiac 
edema (red arrowheads), and cysts (green arrowheads). 
All panels show lateral views, anterior to the left, dorsal to the top. 
Scale bars indicate 200 µm. 
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Fig. 13. Organ laterality in smpx morphants. 
(A-D) Alteration of the wild-type expression pattern of the cardiac-specific marker cmlc2 following 
smpx down-regulation. In comparison to the (A) standard control morphants (SC-MO), smpx-
morphants (smpx-MO) evidence (B) a full cardiac inversion or (C, D) a non-looped heart. 
(E, H) Loss of left-right organ asymmetry documented using a prox1-specific probe. (E) In 
comparison to the standard control embryos (SC-MO), smpx morphants show (F) a complete 
reversal or (G) an undefined asymmetry in the placement of liver and pancreas. (H, I) The 
asymmetric distribution of the medial habenular subnuclei in the diencephalon (red arrowhead) is 
perturbed following smpx knock-down, as clear comparing (H) control embryos (SC-MO) with (I) 
smpx morphants (smpx-MO). 
Abbreviations: V,  ventricle; A, atrium; L, liver; P, pancreas. 
Panels (A-D) show frontal views; all the other panels (E-I) show dorsal views.  
Scale bars indicate 200 µm (A-G), 60 µm (H, I). 
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Fig. 14. smpx down-regulation does not affect the gross anatomy of the ear. (A, B) fgf8 and 
(C, D) pax5 expression at 30 and 48 hpf, respectively. (E, F) Confocal projection of 48 hpf 
morphant ear stained with FITC-phalloidin (green). fgf8 and pax5 WISH show no difference in 
the structure of the anterior macula in the (A, C) standard-controls when compared to (B, D) 
smpx morphants. The gross structure of the whole ear is maintained after smpx down-regulation. 
Abbreviations: am, anterior macula; pm, posterior macula. 
Scale bar indicates 30 µm (A-D), 10 µm (E, F). 
  
  
  
  
24 
Fig. 15. Reduction in cilia number in smpx morphant embryos. Confocal projection of 
immunofluorescence performed with antibody against acetylated tubulin in 48 hpf (A) control- 
and (B) smpx-morphant embryos. smpx morphants display a lower number of cilia in the macular 
regions compared to control embryos. 
Abbreviations: am, anterior macula; pm, posterior macula. 
Scale bars indicate 10 µm.  
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Discussion 
In this study we disclosed the role of the zebrafish small muscle protein X-linked gene, 
smpx, in crucial steps of embryonic development, and identified the potential cause 
leading to SMPX-linked NSHL in human. Furthermore, we pointed out the key role of 
smpx in zebrafish ciliogenesis, suggestive of a potential involvement of SMPX also in 
human ciliopathies. 
Previous works associated SMPX mutations with hearing loss (Huebner et al., 2011; 
Schraders et al., 2011; Abdelfatah et al., 2013). For such reason we embarked upon the 
project of trying modelling hearing loss phenotypes in zebrafish in order to gain insights 
into the events underlying this phenomenon. With this aim, we first investigated for 
smpx activity during zebrafish embryonic development from 0 to 72 hours post 
fertilization (hpf). The RT-PCR assay showed smpx expression starting from the 4-somite 
stage; interestingly, the mRNA at the earliest developmental stages (4 to 8 somites) was 
alternatively spliced, encoding two forms of the protein, a long form of 83 amino acid 
residues, and a short form, lacking of exon 3, of 54 amino acid residues. Indeed, later on 
and up to 72 hpf, only the long mRNA form is detectable. Although this alternative 
splicing has not been yet reported in any other organism before, we revealed the 
presence of several ESTs encoding the short form in other fish species and, intriguingly, 
also in the mammals Heterocephalus glaber and Sus scrofa, suggestive of a more 
widespread event concerning vertebrates. To elucidate the potentially different roles of 
the two protein forms during development, further experiments will be required. 
By means of WISH assays we disclosed smpx expression at the 4-somite stage specifically 
in the Kupffer’s vesicle (KV), a ciliated organ of asymmetry that establish the left-right 
body axis of zebrafish by creating a directional fluid flow through cilia beating (Essner et 
al., 2005). From 10 somites to 24 hpf, smpx was expressed at the level of the somites 
and, at 24 hpf, started to be visible in the heart. At 72 hpf, smpx transcripts were 
detectable in the heart, in the branchial arches, and in the developing muscles of eye 
and pectoral fins. Starting from 36 hpf, smpx specific signal was visible in the ear, 
specifically in hair cells of the anterior and the posterior macula. Being human SMPX 
abundantly and specifically expressed in fetal skeletal muscle, heart and in fetal inner 
ears (Patzak et al., 1999; Schraders et al., 2011), similarly to murine Smpx (Palmer et 
al., 2001), it is possible to conclude that the expression pattern of the gene is well 
conserved between zebrafish and the mammalian ortholog.  
Of particular interest for our project was the expression of the gene in the zebrafish 
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embryonic ear, which allowed us to set up a series of experiments of smpx functional 
ablation in order to assess the effect of the down-regulation on ear development. 
Although the knock-down of the gene did not alter the gross morphology of the inner 
ear, as showed by the conserved normal pattern of fgf8 and pax5 ear-specific markers, 
as well as by the normal aspect of the elaborate cytoskeleton of the hair cells (as shown 
by the phalloidin-mediated F-actin staining), we observed a noteworthy 40% reduction in 
the number of cilia in both the anterior and the posterior macular regions. This data 
strongly support the previously formulated hypothesis (Abdelfatah et al., 2013), 
suggesting that SMPX protein deficiency in human could lead to a progressive hearing 
loss due to damages to the inner hair cells. Furthermore, being the gross morphology of 
the ear essentially normal, it is likely the involvement of Smpx in the maintenance of 
the hair cells rather then their proper development/differentiation, as also suggested by 
Yoon and colleagues (Yoon et al., 2011). In order to analyze this hypothesis we plan to 
follow the development of the cilia in the hair cells at selected time points starting from 
the very beginning of their establishment. Macular organs in zebrafish are important for 
both hearing and for sensing linear acceleration and gravity (Nicolson, 2005). To 
understand if the decrease in the number of cilia in the macular regions may have 
consequences on the vestibular and auditory system in smpx morphants, the next step 
would be to assess embryos hearing capacities by a behavioral screening method that 
relies on the observation of the acoustically-triggered startle response (Bang et al., 
2002).  
As mentioned above, the first site of smpx expression we identified was the ciliated KV, 
the equivalent of the mouse embryonic node, responsible for the body left-right 
patterning. Interestingly, besides ear cilia defects, another striking outcome of our 
functional assay was an abnormal body curvature, a feature usually associated with 
alterations in the ciliogenesis process in zebrafish (Serluca et al., 2009). The potential 
involvement of smpx in cilia defects has been confirmed by the analysis of the position 
of the asymmetric organs in the morphant embryos, which indeed displayed the altered 
left-right patterning of the diencephalic habenular nuclei, the liver, and the pancreas, 
as well as the randomized looping of the heart. On these premises we analysed in more 
details the KV in morphant embryos. Although smpx-deficient embryos displayed a fully 
formed KV, the structure was characterized by a marked decrease in the number of cilia 
(less of 50%) when compared to the KV of control embryos, indicative of a KV-lack of 
functionality determined by the drastic drop in the amount of cilia, in agreement with 
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previous studies supporting the hypothesis that a defective flow within the KV, due to 
the reduced number of cilia, resulted in heterotaxy, the randomization of left-right 
visceral organ situs (Sampaio et al., 2014). As for the ear hair cells, in order to 
discriminate in between cilia development versus maintenance, we plan to follow the 
development of the KV since the beginning of its formation. 
The wealth of data reported in this study strongly supports the notion of the important 
role of smpx in the process of developing and/or maintaining zebrafish cilia. Such 
evidences shed some light on the cause of hearing loss in SMPX-defective patients, 
allowing us to propose zebrafish as a suitable system to elucidate the mechanisms lying 
behind the disability. Additionally, this work identified a novel, unexpected effect of 
Smpx-deficiency on zebrafish embryos, meaning impairment of the left-right patterning 
of visceral organs. On this basis, considering the high degree of gene function 
conservation between zebrafish and human, it is possible to hypothesize potential links 
concerning SMPX and heterotaxy. Indeed, despite the heavy genetic contribution to 
human heterotaxy, the vast majority of cases remain unexplained; in this scenario, the 
employment of animal models such as zebrafish may speed up the identification of novel 
genetic causes leading to this heritable disorder. At this juncture, we are planning the 
screening of a cohort of patients affected by X-linked heterotaxy already tested for the 
known loss of function mutations in ZIC3, the only gene associated with situs inversus 
and positioned on the X chromosome (Ware et al., 2004). 
In conclusion, this study contributes to the comprehension of the link between SMPX and 
human hearing loss, delivers a novel heterotaxy-candidate gene, and finally provides a 
robust animal tool for the future elucidation of the mechanisms behind both 
deafness/hearing loss and heterotaxy.   
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Experimental Procedures 
Zebrafish Strains 
We used AB zebrafish strains for all experiments. Breeding wild type fish of the AB strain 
were maintained at 28°C on a 14 h light/10 h dark cycle. Wild-type zebrafish embryos 
were obtained through natural matings, raised at 28°C in the presence of 0.002% 
Methylene Blue and 0.003% PTU (1-phenyl-2-thiourea) to block pigmentation, and staged 
as described (Kimmel et al., 1995). 
 
RT-PCR 
Total RNA from 10 samples (an average of 30 embryos per sample) corresponding to 10 
different developmental stage embryos (1–2 cells, Oblong, 30% epiboly, 90% epiboly, 
tailbud, 2 somites, 4 somites, 8 somites, 24 hpf, 48 hpf and 72 hpf) was extracted with 
the SV Total RNA Isolation System (Promega) and reverse transcribed with the ImProm-
II™ Reverse Transcriptase kit (Promega), according to manufacturers' instructions. The 
following primers were used for the subsequent PCRs:  
smpx_F0: 5'-TTGACATTTGTGTCTGACACCA (forward) 
smpx_F1: 5'-ACTGCACACAATGTCAAAACA (forward) 
smpx_R1: 5'-CACCTGAGCCAATTTAGTCTT (reverse) 
β-actin_F: 5'-TGTTTTCCCCTCCATTGTTGG (forward) 
β-actin_R: 5'-TTCTCCTTGATGTCACGGAC (reverse)  
PCR products were loaded and resolved onto 2% agarose gels. 
The smpx_F1/smpx_R1 amplicon has been gel extracted and cloned in the pSC-A-
amp/kan and pCMV-SC vectors (Strataclone) in order to in-vitro transcribe the smpx-
specific sense/antisense RNA probes and the synthetic mRNA, respectively. 
 
Morpholino and mRNA microinjection 
Embryos were injected at the one- to four-cell stage with ~4 nl using freshly pulled 
micropipettes attached to the FemtoJet precision pressurized injector (Eppendorf); the 
dye tracer rhodamine dextran (Invitrogen) was also coinjected. To repress smpx mRNA 
translation, the following ATG-targeting morpholino (Gene Tools, LLC) has been 
synthesized: 5'-AGCAGCAGGAACGTGGACACAACTG-3’. smpx morpholino (smpx-MO) was 
used at the concentration of 0.35 pmole per embryo in Ringer’s solution (pH 7,3) 
according to the Gene Tool’s protocol. As control a standard control morpholino 
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oligonucleotide (SC-MO) has been injected. For Smpx over-expression, synthetic capped 
smpx mRNA was synthesized with the mMessage mMachine® SP6 kit (Ambion) and 
injected at the concentration of 300 pg per embryo. 300 pg/embryo of synthetic capped 
GFP mRNA was synthesized with the same Ambion kit and injected as control. 
 
In-situ hybridization  
Whole mount in-situ hybridization (WISH), was carried out as previously described 
(Thisse et al., 1995) on embryos fixed overnight in 4% paraformaldehyde/PBS, then 
rinsed with PBS-Tween, dehydrated in 100% methanol and stored at -20°C until 
processed for WISH (Jowett and Lettice, 1994). Antisense riboprobes were previously in-
vitro labelled with modified nucleotides (digoxigenin or fluorescein, Roche). Embryos 
were imaged by Digital Camera DCF480 (Leica) and software LAS (Leica Application 
Suite, Leica) on a MZFLIII microscope (Leica). 
 
Phalloidin staining and immunostaining 
Immunostaining was performed according to routine protocol. Briefly, fresh embryos 
were fixed overnight in 4% paraformaldehyde/PBS, then incubated with mouse anti-
acetylated α-tubulin IgG (Sigma) and goat anti-mouse Alexa488 (Invitrogen). Embryos 
were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) to visualize cell nuclei.  
For visualization of actin using phalloidin staining, embryos were fixed as above, 
followed by overnight incubation in 1:20 FITC-phalloidin (Sigma). Embryos were 
confocally imaged with the TCS SP5 microscope (Leica). The number of cilia and their 
location was determined from inspections of z-stacks of up to 200 0.2-1.0 µm optical 
sections. z-stacks were converted into projections that merged optical sections into one 
image.  
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Abstract
Understanding the role of microenvironment in cancer growth and metastasis is a key issue for cancer research. Here, we
study the effect of osmotic pressure on the functional properties of primary and metastatic melanoma cell lines. In particular,
we experimentally quantify individual cell motility and transmigration capability. We then perform a circular scratch assay
to study how a cancer cell front invades an empty space. Our results show that primary melanoma cells are sensitive to a
low osmotic pressure, while metastatic cells are less. To better understand the experimental results, we introduce and study a
continuous model for the dynamics of a cell layer and a stochastic discrete model for cell proliferation and diffusion. The two
models capture essential features of the experimental results and allow to make predictions for a wide range of experimentally
measurable parameters.
1 Introduction
The microenvironment is a key factor in tumour development
and progression. Its influence on the behaviour of cancer cells
is to a great extent mediated by the composition, structure, and
dimensionality of the extracellular matrix, the polymeric scaf-
fold that surrounds cells within tissues. Research shows that
the mechanical properties of tumour microenvironment can fa-
cilitate or oppose tumour growth and dynamics, although this
effect is poorly understood. Mechanical stresses such as those
experienced by cancer cells during the expansion of the tu-
mour against the stromal tissue have been shown to release
and activate growth factors involved in the progression of can-
cer [14]. Moreover, the stiffness of the matrix surrounding
a tumour determines how cancer cells polarize, adhere, con-
tract, and migrate, thus regulating their invasiveness [14]. An-
other possibility is that mechanical stresses directly regulate
the growth and death rates of cancer cells. Recently, Montel
et al. have explored this possibility, investigating the effect
of a constant stress applied on cellular spheroids over long
time scales by inducing osmotic pressure by a solution of dex-
tran, a biocompatible polymer which is neutral and can not
metabolised by mammalian cells [11, 12]. Using a similar
method, some of us recently reported that a constant low os-
motic pressure (1KPa) affects more strongly the proliferative
capability of primary human melanoma cells (IgR39) in com-
parison to the corresponding metastatic ones (IgR37) [20].
Furthermore, a computer simulation analysis of the growth
of melanocytic nevi inside epidermal or dermal tissues shows
that the shape of the nevi is correlated with the elastic proper-
ties of the surrounding tissue[20].
Several studies in the literature reported important changes
in cellular functioning due to osmotic pressure [15, 13], but
the stresses involved (in the MPa range) were orders of mag-
nitude larger than those (in the kPa range) studied in Refs.
[11, 12, 20]. It is interesting to notice that compressive stresses
of slightly less than 1 kPa applied through a piston were re-
cently found to induce a metastatic phenotype in cancer cells
[21]. In a recent paper, Simonsen et al. showed that intersti-
tial fluid pressure (IFP) was associated with high geometric
resistance to blood flow caused by tumour-line specific vas-
cular abnormalities in xenografted tumours from two human
melanoma lines with different angiogenic profiles [18]. In an-
other recent paper, Wu et al investigated how nonlinear inter-
actions among the vascular and lymphatic networks and pro-
liferating tumour cells might influence IFP transport of oxy-
gen, and tumour progression [22]. They also investigated the
possible consequences of tumour-associated pathologies such
as elevated vascular hydraulic conductivities and decreased
osmotic pressure differences. All these parameters might af-
fect microenvironmental transport barriers, and the tumour in-
vasive and metastatic potential, opening interesting new thera-
peutic perspectives. In general, understanding the influence of
mechanical stress on cancer growth could shed new light on
tumour development and progression. Studies present in the
literature also use hypertonic conditions, but the effects are
always observed at high osmotic pressure [7, 10].
In this paper, we show that low osmotic pressure (1KPa)
beside proliferation, which was the focus of previous works
[11, 12, 20], also modulates key functional biological aspects
of cancer cells such as their motility and transmigration, possi-
bly contributing to the acquisition of a more aggressive pheno-
type. Melanoma is an aggressive, radio- and chemo-resistant
tumour which becomes impossible to cure when metastasised.
Therefore, a pressing clinical problem in the treatment of
melanoma is to understand how to stop or prevent the capa-
bility of the tumour to give rise metastasis. Using an interdis-
ciplinary approaches combining cellular biology and theoreti-
cal physics, here we show that a low osmotic pressure (1KPa)
leads significant changes in cell F-actin organization compro-
mising the capability of the cells to move and transmigrate. In-
terestingly, osmotic pressure shows a more efficacy on the pri-
mary human melanoma cell line with respect to the metastatic
once belonging to the same patient. We perform quantitative
analysis on the experimental data and extract parameters for
cell motilities that we can then use in a continuum theory and
a discrete model for cancer cell front dynamics. Overall, our
results show that osmotic pressure can contribute to the selec-
tion of subpopulation in the primary human melanoma cells
contributing to the acquisition of a more aggressive pheno-
type.
2 Experimental results
2.1 Effect of osmotic pressure on F-actin organization
The organization of F-actin in the two human melanoma cell
lines is shown in Figure 1 under normal growth condition or
1KPa osmotic pressure without or with collagen as physiolog-
ical substrate. In both cell lines, 1KPa induces a rearrange-
ment in F-actin organization (Fig. 1). In particular in IgR39,
1KPa osmotic pressure induces the appearance of filopodia
and stress fibers (Fig. 1a-b) Similar changes have been shown
plating the cells on a collagen pre-coated Petri dish (Fig. 1c-
d). The metastatic cell line IgR37 shows, however, a little
effect of osmotic pressure displaying a more elongated shape
(Fig.1e-f).
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Fig. 1 Effect of osmotic pressure on F-actin. Subconfluent cells
were plated on 33cm2 Petri dish untreated or pre-coated with type I
collagen. After 6 days the cells were fixed with 3.7%
paraformaldeide and incubated with Red-Falloidin for 30min at
room temperature. The nuclei were counterstained with DAPI and
the slides were mounted with Pro-long anti fade reagent
(Invitrogen). The images were acquired using a Leika TCS NT
confocal microscope. Panel a-d represent IgR39 cells and panel e-f
IgR37 cells. Scale bar is 50µm
2.2 Effect of osmotic pressure on transmigration capabil-
ity of IgR39 and IgR37 human melanoma cells
An important function needed by cancer cells in order to
metastasise is the ability to bypass an obstacle such as an
endothelial wall. To simulate this process in vitro, we use
a transwell assay counting the number of cells that are able
to pass through 8µm wide pore after 6 hours in presence
of a chemoattractant (10%FBS). Without chemoattractant the
cells barely overcome the obstacles, although metastatic cells
are intrinsically more capable to do this (Table 1). Figure
2 shows a significantly decrease of transmigration capability
when cells are treated for six days with a 1kPa osmotic pres-
sure. The decrease is by a factor 4 for IgR39 and by a factor 2
for IgR37 with respect to the untreated ones (Table 1).
2.3 Effect of osmotic pressure on circular scratch assay
of IgR39 human melanoma cells.
We study the biological effect of 1kPa osmotic pressure on
the capability of the cells to cover a free space using a circular
scratch assay. As shown in Fig. 3, the circular shape of the
ring is maintained during up to 96 hours, suggesting that the
cells move isotropically into the free space. Moreover, in Ta-
ble 2 is shown that osmotic pressure induces a little effect on
the migration capability to cover the free area (around 4%). By
IgR39 0kPa IgR37 0kPa IgR39 1kPa IgR37 0kPa
without FBS 103±1.4 602±74 68±11 387±57
+FBS 1704±388 1925±173 269±21 825±125
Table 1 Result of the transwell assay for primary and metastatic human melanoma cells with and without osmotic pressure. The results are
the mean number of cells crossing pores averaged over three independent experiments. Error bars correspond to the standard error.
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Fig. 2 Transwell Assay. 70000 cells are plated to each transwell
insert (8µm pores) into the upper chamber. In the lower chamber
600µl medium without FBS (-FBS) or when 10% FBS is added.
After 6 hours the cells are fixed and stained in a 20% methanol/0.1%
crystal violet solution for three minutes at room temperature,
followed by washing in deionized water to remove redundant
staining. Non-migrated cells remaining at the upper side of the
membranes, are carefully removed with cotton swabs and inserts are
dried in darkness overnight. Pictures of the entire Petri dish are
made with a Leika MZFL11 microscope mounted with a camera
Leika DFC 32. The blue cells are counted using the magnified
images (25X) and then calculated for the whole surface (32cm2).
observing the cells at higher magnification, we notice that the
structure of the front is affected by osmotic pressure becom-
ing more scattered 3b-c. The effect might be due to changes
in either their proliferative capability or in their motility due
to cytoskeleton changes observed in Fig. 1. Colony forma-
tion assays reported in Ref. [20] for the same cells, show that
the rate of division decreased from kdiv = 0.60 to kdiv = 0.51
under the effect of 1kPa of osmotic pressure.
We also investigate if the proliferative capacity of the cells
are different at the border of the ring or at the edge of the Petri
dish. As shown in Fig. 4, no significant differences of pro-
liferation have been shown using Ki67, a known proliferative
marker, between the centre of the dish and the edge (Fig. 4
shows the expression at 72 hours, similar results was obtained
at 24 and 48 hours). Regarding to IgR37 we did not carry
out this kind of experiment since these cells do not grow as a
monolayer and it is impossible to get a homogeneous conflu-
ent layer.
Fig. 3 Circular scratch assay. Cells were plated on 33cm2 Petri
dish with at the center a ring (32mm2) at confluence. The day after
the ring was removed and the cells were fixed with 3.7%
paraformaldeide and stained with hematoxillin/eosin solution at
different times. The same experiment was carried out on cells
treated with 1KPa osmotic pressure. Panel a shows a typical
experiment at magnification 8X; Panel b-c show details from the
same images at magnification 40X. The images were acquired with
LEICA MZFLIII mounted with a camera LEICA DFC320.
2.4 Osmotic pressure affects cell motility
To investigate the effect of osmotic pressure on cell motil-
ity, we reconstruct cell trajectories from confocal images (see
5a). We use IgR39 cells since these cells are the ones that
are most affected by osmotic pressure [20]. To quantify
cell motility we compute the typical width of the trajectories
W = h(R(t) hRi)2i, where the average is taken over all time
frames and 4 different cells for each experimental condition.
Fig. 5b shows that osmotic pressure reduces the average ex-
cursions of the cells. Next, we compute the time dependence
of the mean square displacement h(R(t+ t 0) R(t 0))2i which
Time [hours] Pressure [KPa] Ring area [mm2] % of area covered
0 0 32 0
48 0 16 50
48 1 16.5 48
72 0 15.5 52
72 1 16 50
96 0 11.2 68
96 1 11.8 65
Table 2 The table shows a typical example of the free circle area and the percentage of covered area obtained from Fig. 3.
increases roughly linearly in time (Fig. 5c) as would be ex-
pected for a Brownian motion. The slope of the linear slope
can be used to estimate the diffusion coefficient resulting in
D = 0.016(µm)2/s at 0kPa and D = 0.004(µm)2/s at 1kPa.
To confirm the Brownian nature of the process, we compute
the power spectrum S(w) of the trajectories, showing that it
decays approximately as 1/w2 as expected for a random walk.
Fig. 4 Ki67 Immunohystochemistry IgR39 cells were plated on
33cm2 Petri dish with at the center a ring (32mm2) at confluence. 72
hours after the ring was removed and the cells were fixed with 3.7%
paraformaldeide and stained overnight with anti-mouse Ki67 (1:100,
DAKO). After a brief incubation for 30min with biotinylated
anti-mouse secondary antibody(Dako, 1:100), the cells were
incubated with streptavidin (Dako, 1:350) conjugated to peroxidase
for 30min. Color was routinely developed using DAB peroxidase
substrate kit (Vector) up to 10 min and coverslipped with a
permanent mounting medium.
3 A continuous model for advancing cell front
Since the main objective of our work is to study the effect
of mechanical stress on an layer made of cancerous cells, we
propose a physical model to explain and quantify the observa-
tions. As shown in Table 2 , we get a strong decrease of the
surface hole, about 50%, the first 2 days, then a period without
proliferation followed by a new decrease which is less abrupt.
The effect is a little less acute if an over-pressure is added via
addition of dextran. For an advancing layer under chemotaxis,
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Fig. 5 Cell motility. Subconfluent cells plated in a 35cm2 Petri dish
untreated or treated for 6 days with 1kPa of osmotic pressure are
transfected with H2B-GFP plasmide. Pictures are made on a
confocal microscope (Leica TCS SP5 AOBS with resonant scanner,
equipped with a 20X, 0.5 NA, dry objective) every 4 minutes for 14
hours. a) Typical trajectories for IgR39 cells untreated and under
osmotic pressure. b) The width of the trajectories is reduced under
osmotic pressure. c) The average displacement grows roughly
linearly with a typical slope that depends on the osmotic pressure. d)
The Brownian nature of the motion is confirmed by the power
spectrum of the trajectories that decays as w 2.
a continuous model has already been proposed by [2, 3], but
these works are not concerned by a proliferative layer submit-
ted eventually to an overpressure due to an osmotic solution.
In addition, proliferation is not considered in the advance of
a layer experimentally but here our experiment clearly shows
that it cannot be discarded.
Let us consider a layer of constant thickness in a domain
W with a border dW. The cell displacement in W is mostly
driven by the cell proliferation, but at the border the cells may
be more proliferative eventually and even detach and move
freely. Due to proliferation, the mass conservation equation is
then transformed into:
∂r0
∂ t
+~—(r0~V ) = kv(P˜ Ph), (1)
where Ph is the homeostatic pressure for which cell prolifera-
tion just compensates apoptosis, r0 is the constant mass den-
sity, ~V is the velocity at an arbitrary point of W. This sim-
ple idea about regulation in living systems is due to Claude
Bernard, a french physiologist, in 1865 [4]. Mathematically,
such a continuous model is valid at a scale larger than the
cell size and the velocity is an averaged quantity on a sam-
ple of intermediate scale between the single cell and the full
layer. Adding dextran to the solution increases the pressure P˜,
slightly inhibiting the proliferation rate. For a layer crawling
on a substrate in strong adhesion, the second Newton’s law of
dynamic simplifies into a Darcy law ([8, 2])
~V =  1
M
—P˜, (2)
where the mobility coefficient M is related to the friction co-
efficient. Combining both equations gives:
DP a2P= 0 with P= P˜ Ph (3)
and a2 = kvM/r0. At the free interface, boundary conditions
include the mechanical equilibrium and the front velocity. The
pressure at the layer border P˜i is equal to the pressure of the
solution (if capillary effect is neglected). It is smaller at the
interface dW than in the layer bulk W for a proliferative layer.
The interface velocity ~dWt is given by the velocity of the cells
at the interface which may be different from the cells in the
bulkW. Indeed, these peripheral cells have more room both for
displacement and proliferation. Then the normal front velocity
~dWt is given by
~N · ~dWt =  1M~N ·
~—P+~N ·~vs (4)
where~vs may represent a specific proliferation rate of the bor-
der cells. It may exist other boundary conditions due to the
geometry of the experiment, it is why we consider now 3 dif-
ferent growth geometries.
3.1 Growing circular disc
We imagine a disc of a cell monolayer and assume that the
growth process preserves the circular geometry. Eq.(3) for the
pressure P = P˜ Ph is then transformed into an ordinary dif-
ferential equation of second order:
1
R
d
dR
 
R
dP
dR
 
= a2P (5)
The regular solution at the origin is the modified Bessel func-
tion of zero order I0 so
P(R) = Pi
I0(aR)
I0(aRi(t))
(6)
and Pi = P˜i   Ph is negative, being fixed by the nutrient
medium, whatever the hole radius Ri(t). From Darcy’s law
(Eq.(2)), we derive the growing velocity at the interface:
~N ·dWt = R˙i(t) = Pi aM
I1(aRi(t))
I0(aRi(t))
(7)
which is an implicit equation for the time variation of the ra-
dius which can be solved numerically. However one can make
an asymptotic analysis of Eq.(7) and gets a constant growth
rate at long times :
R˙i(t)|t!•! Pi aM
and a radius growing linearly in time. However, it is to be
noticed that a constant proliferation rate into Eq.(1) will lead
to an exponential time behaviour for the radius so to follow
the growth expansion of the layer at long times may be a good
test for the validation of the model.
3.2 A hole in an infinite layer
In this case, we can accept the irregular Bessel function at the
center K0 as the solution of Eq.(5), but not I0, which grows
exponentially. The solution reads
P(R) = Pi
K0(aR)
K0(aRi(t))
. (8)
The pressure P vanishes at infinity where there is no cell pro-
liferation. The velocity given by Darcy’s law is then:
R˙=
a
M
Pi
K1(aR)
K0(aRi(t))
(9)
being negative as Pi and vanishing as R!• as expected. Here
again the radius of the hole is given numerically if we take
Eq.(4) on the interface. In addition, the radius velocity di-
verges when the total cover of the hole is reached, and the
continuous model stops to be valid for Ri(t)! 0.
3.3 The circular scratch assay
Here we focus on the geometry of the circular scratch assay
which is made of a planar annulus of cells limited by a plastic
circular wall at R = Re. The outer interface is rather diffuse
but an average circular border can be defined. In addition a
thin circular ring (of thickness d ) with smaller cell density
can be observed appearing less contrasted than the inner core.
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Fig. 6 Relative area of the hole as a function of time for theory and
experiments (see Table 2). Parameters for the theory are Pi = 1 for
0kPa and Pi = 0.98 for 1kPa, a = 0.71,d = 0.3 (with initial radius
1 ), t = 1.
We will adapt the previous model to this inhomogeneous ring
which has a density ri for R between Ri(t) and Ri(t)+d while
the density in the bulk (Ri(t)+d < R < Re) is called re . We
take constant both r values. Moreover, in vitro, it has been
shown that in confluent layers, live cell extrusion is induced to
recover the homeostatic state in case of over-crowding and it
is clear that the border allows more easily such extrusion [9].
So we presume that ri < re.
Because the layer geometry excludes R = 0 and R ! •,
possible solutions for Eq.(5) are superposition of I0 and K0
and we get
Pi(R) =
Pi
1+b
  I0(aiR)
I0(aiRi(t))
+b
K0(aiR)
K0(aiRi(t))
 
(10)
with a2i = kvM/ri. The velocity of the cells at the outer border
being :
R˙i = ai
M
Pi
1+b
(
I1(aiR)
I0(aiRi(t))
 b K1(aiR)
K0(aiRi(t))
) (11)
Pi keeps the same definition as before : the pressure in the
solution minus the homeostatic pressure. For Ri(t)+d < R<
Re we have:
Pe(R) = Pe
  I0(aeR)
I1(aeRe)
+
K0(aeR)
K1(aeRe)
 
)  t (12)
t being an evaporation rate of cells as mentioned by [9] and
R˙e = ae
M
Pe
  I1(aeR)
I1(aeRe)
  K1(aeR)
K1(aeRe)
 
(13)
with a2e = kvM/re. In Eqs.(12,13), we have applied the
cancellation of cell velocity at the exterior border Re. We
have 2 unknowns: the coefficient b and Pe which are fixed
by the mechanical equilibrium Pi(Ri(t)+ d ) = Pe(Ri(t)+ d )
and the continuity of the flux: ridPi/dR = redPe/dR for
R = Ri(t) + d . The principle of such analysis is simple but
requires also a numerical solution that we present in Fig(6) in
comparison with experimental data. However, varying param-
eters, the comparison with the experiment is mostly controlled
by the quantity aPi/(MRi) =
p
kv/(r0M)R 1i which is the in-
verse of a typical time. In the experiment the time scale is
the day. it turns out that aRi of order one is a good fitting
value for the experiment so a ⇠ 0.7 ·103. Then taking the fact
that experimentally 1 kPa is enough to vary the proliferation
rate of 1 cell by 0.09 gives kv/r of order 10 9 giving finally
M ⇠ 0.5 · 1015 in SI units . A naive estimation consisting of
a pico-Newton force acting on a cell of micro-size with the
velocity of the layer that we estimate from Table 2 as 2 ·10 6
mm/s gives the same estimation of 1015 in SI units. Having
all the data we can estimate from Eq.(11), the departure from
homeostatic pressure of 25 kPa.
4 Computational model of cell duplication and
movement
To understand how the morphology of the front in the circular
scratch assay depends on the interplay between cell division
and mobility, we simulate a simple lattice model including
mechanisms for cell division and motility, with the relative
rates of the two as the tunable parameter. The model is de-
fined on a square lattice of linear size L= 700, in which all the
sites are occupied by cells except those inside a circle of radius
r = 320. This choice corresponds to the ratio of cell size and
the radius of the initial empty circle used in the experiments.
The dynamics of the model is defined as follows: First, a ran-
dom choice is made of whether a cell division (probability
Pdiv or diffusion (probability Pdiff = 1 Pdiv) attempt is made.
Then, an occupied site with coordinates (x,y) is selected ran-
domly, followed by a random selection of one of its four near-
est neighbours. If that nearest neighbour site is unoccupied, a
new cell is created there (cell division) or the cell at (x,y) is
moved there (diffusion). If the chosen nearest neighbour site
of (x,y) is occupied, nothing happens - the cell cannot move
on top of another cell, nor can a new cell be created there.
In any case, time is incremented with an amount proportional
to 1/N, where N is the total instantaneous number of cells
present in the system. Then, a new Monte Carlo step is started
by repeating the steps above. The simulation is continued until
a cell reaches a small region around the center of the system.
We simulate the model by varying the probability for cell divi-
sion Pdiv (and thus the probability of diffusion Pdiff = 1 Pdiv)
between 0 and 1. These probabilities correspond to ratios of
the rates for the two processes, kdiv/kdiff = Pdiv/(1 Pdiv). The
above protocol then corresponds to using a unit of time pro-
portional to 1/(kdiv+ kdiff), and consequently, velocities are
measured in units of kdiv+ kdiff. Results are averaged over 10
realizations for each case.
In Fig. 7, we report typical configurations of the ring as-
say obtained by numerical simulations for different values of
kdiff/kdiv. When this ratio is large the interface is very diffuse,
with several cells moving ahead of the front. As the ratio de-
creases, the front is more sharp, but still remains rough due
to the randomness in the division process. When we compare
these results with experiments, we see that fronts are more dif-
fuse under osmotic pressure. This is consistent with the fact
that kdiff/kdiv increases with osmotic pressure. We can esti-
mate kdiff ' D/a2, where a is the typical cell diameter. From
Fig. 1, we obtain that a ' 20µm at 0kPa and a ' 50µm at
1kPa. Using our measurements for D and kdiv [20], we obtain
kdiff/kdiv ' 0.9 at 0kPa and kdiff/kdiv ' 1.7.
In the model, we have also quantified the front velocity and
the roughness that are reported in Fig. 8. The velocity is found
to decrease when diffusion predominates over cell division,
suggesting that the process of ring closure is dominated by
cell division (Fig. 8a). Fig. 8b shows instead that the front
roughness increases when diffusion becomes more important.
5 Discussion
Melanoma is one of the most aggressive tumours and practi-
cally impossible to cure once it becomes metastatic. Hence,
one of the main goals of research is to understand the pro-
cesses involved in metastasis. The classical approach is to
consider the biological properties of the cell trying to iden-
tify biological markers. Here, we investigated this problem
from a different point of view, focusing on the possible role
of mechanical stress in the selection of a more aggressive cell
subpopulation. Recent research has shown the involvement of
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Fig. 7 Simulated ring assay. Illustrative examples of the rings
obtained for different ratios of the rates of diffusion and division.
mechanical stresses, such as the osmotic pressure, in the mod-
ulation of critical biological properties [14, 11, 12, 20, 21].
Therefore, we have investigated the effect of low osmotic pres-
sure on two cell lines belonging to the same patient, IgR39 and
IgR37 a primary and metastatic cell line, respectively. Our re-
sults show that a low osmotic pressure which gives little ef-
fect on cell proliferation on the primary human melanoma cell
line [20], induces significant changes on the F-actin organiza-
tion,with the appearance of filopodia and stress fibres. These
changes are more evident in primary human melanoma cell
lines than in metastatic ones. Earlier studies on endothelial
cells have shown that an osmotic pressure around 1.6KPa in-
duces an elongation of the cells due to a rearrangement of the
cytoskeleton [1, 17], in agreement with our results. In human
breast cancer, mechanical compression has an effect on the
contractility of the cells suggesting the presence of a mechano-
regulation which is able to integrate external physics stimula-
tion into cytoskeletal changes and therefore cell phenotypes
[21].
A critical question is whether F-actin rearrangement has a
functional effect on biological properties of cancer cells such
as their capability to move or to invade. Metastasis is indeed
an integrated process composed by several steps. At least two
key aspects play a critical role in this process: first the capa-
bility of the cell to move and then the capability of the cell to
squeeze through the endothelium. To reproduce in vitro these
two processes we have carried out the circular scratch assay
which gives the possibility to study the movement of the cell
into an open space and the transwell assay which investigates
the capability of the cell to squeeze through a pore of a fixed
size. Primary human melanoma cell are less able to move
through fixed size pores using transwell assay in comparison
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Fig. 8 Front velocity and roughness from numerical
simulations. a) The front velocity as a function of the ratio of the
rates of diffusion and division. b) The front roughness as a function
of the ratio of the rates of diffusion and division.
to metastatic cells. Moreover, interestingly, low osmotic pres-
sure leads to a reduced capability to transmigrate in both cell
lines, however, the primary human melanoma cell line is more
affected. The circular scratch assay confirms an inhibitory ef-
fect of osmotic pressure on the capability to move of the cells.
This is also confirmed by quantitative measurements of cell
motility from series of confocal images.
In other to better understand the biophysical aspects of the
circular scratch experiments, we have approached the problem
theoretically and numerically. We have derived a continuum
theory for the growth of a single layer of cells with different
boundary conditions such those used in the circular scratch
assay. This allows to obtain quantitative predictions for the
dynamics of the cell front. In particular, we calculate the de-
pendence of the front velocity on a few experimentally mea-
surable parameters such as the cell division rate and motility.
The theoretical results are in good agreement with the exper-
iments. The main limitation of the theoretical model is that
it does not include noise and fluctuations which are obviously
present in our experiments. To deal with this issue in a sim-
ple way, we introduce a discrete lattice model of cell prolif-
eration and diffusion which we simulate in similar conditions.
The discrete model allows to reproduce the experimentally ob-
served roughening of the cell front.
This combination of theoretical and numerical models al-
lows to understand better the role of motility and cell division
under osmotic pressure and provide a useful tool to explore
the effect of experimentally relevant parameter. Experimen-
tally, fronts appear to be more diffusive under osmotic pres-
sure and this is explained by our model when we input into
it parameters measured from other independent experiments.
Both cell proliferation and motility rates are reduced by os-
motic pressure, which also changes the shape of cells making
them thinner and more elongated. The combination of this
factor leads to an increase of kdiff/kdiv under osmotic pressure.
All together our results show how low osmotic pressure
changes functional properties of the tumour cells leading to
the selection of subpopulation that appear more aggressive.
These results appear in agreement with previous papers show-
ing a role of osmotic pressure in the selection of more resistant
subpopulation [6, 14, 16].
6 Material and Methods
6.1 Dextran solution
A master solution of dextran at 10% (w/v) was formed (Dex-
tran from Leuconostoc spp, Fluka) and diluted to the desired
concentration with complete medium. Transformation from
dextran concentration to osmotic pressure was performed ac-
cording to the calibration curve measured in Ref. [5].
6.2 Cell lines
Human IGR39 and IGR37 cells were obtained from Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmbH
and cultured as previously described [19]. IGR39 was derived
from a primary amelanotic cutaneous tumour and IGR37 from
an inguinal lymph node metastasis in the same patient. The
cells were plated on pre-coated collagen type I plates accord-
ing to the manufacturer’s instructions for further experiments
when specified in the results section.
6.3 Cell transfection
Cells were transfected with 1µg H2B-GFP plasmide (plas-
mide 116980, Addgene) according to the manufactories in-
struction of SuperFect Transfection reagent by Qiagen. The
cells were analyzed by time lapse using Leica TCS SP5 AOBS
with resonant scanner, equipped with a 20X, 0.5 NA, dry ob-
jective (Leica Microsystems GmbH, Wetzlar Germany) with
fluorescence under 5% CO2 and 37C temperature.
6.4 Immunofluorescence-Phalloidin
Subconfluent cells grown on glass coverslip were fixed with
3.7% parafolmaldeide in PBS for 10min, permealized with
0.5% Triton X-100 in PBS for 5min at room temperature
and. stained with 200µl of 100nM Acti-stainTM 555 Phal-
loidin (TebuBio, Cat. # PHDH1) for 30min. DNA was coun-
terstained for 30s with 200µl of 100nM DAPI and the slides
were mounted with Pro-long anti fade reagent (Invitrogen).
The images were acquired using a Leika TCS NT confocal
microscope.The same experiments were carried out using pre-
treated collagen type I coverslips (Sigma).
6.5 Immunohystochemistry-Ki67
Cells plated for ring assay were fixed with
3.7%paraformaldeide for 10min at room temperature, incu-
bated for 1hr in 1%BSA, 10NGS, 0.3M glycin, 0.1%Tween
in PBS and overnight with anti-Ki67 (clone MIB-1, Dako,
1:100 cod.) at 4C. All the sections were incubated for
30min with biotinylated anti-mouse secondary antibody in
PBS (Dako, 1:100). This was followed by incubation with
streptavidin (Dako, 1:350) coniugated to peroxidase in PBS
for 30min, and by a brief rinse in PBS. Color was routinely
developed using DAB peroxidase substrate kit (Vector) up
to 10 min, rinsed in distilled water, and coverslipped with
a permanent mounting medium. The images were acquired
using a microscope Leica MZ FLIII mounted with a camera
Leica DFC320.
6.6 Circular scratch assay
Cells were plated on 33cm2 Petri dish with a ring at the center
each (Sigma cod. z370789, diameter: 6.4mm, area 32mm2) to
reach 70-80% confluence as a monolayer. When they were at
confluence, the ring was removed and the cells were fixed with
3.7% paraformaldeide at different times (from 4 to 96hrs) and
stained with hematoxillin-eosin. The images were acquired
using a Leica MZFL11 microscope mounted with a Camera
Leica DFC 32 at different magnification (8, 16 and 25X). To
quantify the free area and the correspondent percentage of
covered area calculated we used Gimp (GNU Image Manip-
ulation Program).
6.7 Transwell migration assay
Migration experiments were conducted using a conventional
24-well Transwell system (6.5 mm TranswellH (# 3422),
CorningH, NY, USA) with each well separated by a micro-
porous polycarbonate membrane (10 mm thickness, 8 mm
pores) into an upper (insert) and a lower chamber (well) ac-
cording to [16]. After 24 hours of serum deprivation, cells
were detached, counted and resuspended in growth media
without FBS to obtain equal cell densities (296000 cells/cm2).
A volume of 250 µl containing 70000 cells was plated to
each insert and 600 µl medium was added to the wells.
As chemotactic factors, a medium containing 10% FBS was
used. After 6 hours the cells were fixed and stained in a
20% methanol/0.1% crystal violet solution for three minutes
at room temperature, followed by washing in deionized wa-
ter to remove redundant staining [16]. Non-migrated cells
remaining at the upper side of the membranes were care-
fully removed with cotton swabs and inserts were dried in
darkness overnight. The following day at stained membranes
were made pictures using a transmitted-light microscope (Le-
ica MZFL11 microscope mounted with a camera Leica DFC
32) at different magnification (8, 16 and 25X). The blue cells
were counted using the magnified images (25X) and then cal-
culated for the whole surface (32cm2).
6.8 Cell tracking
Cell tracking has been done in ImageJ by first projecting
the confocal stacks (maximum intensity) and then finding the
maxima for different frames.
6.9 Statistical analysis
Statistical significance was evaluated using the
Kolomogorov-Smirnov non parametric test (see
http://www.physics.csbsju.edu/stats/KS-test.html).
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Abstract
Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized by two molecularly dis-
tinct self-renewing leukemic stem cell (LSC) populations most closely related to normal progenitors and organized
as a hierarchy. A requirement for WNT/β-catenin signaling in the pathogenesis of AML has recently been suggested
by a mouse model. However, its relationship to a specific molecular function promoting retention of self-renewing
leukemia-initiating cells (LICs) in human remains elusive. To identify transcriptional programs involved in the main-
tenance of a self-renewing state in LICs, we performed the expression profiling in normal (n= 10) and leukemic (n =
33) human long-term reconstituting AC133+ cells, which represent an expanded cell population in most AML
patients. This study reveals the ligand-dependentWNTpathway activation inAC133bright AMLcells and shows a diffuse
Abbreviations: AML, acute myeloid leukemia; LSC, leukemic stem cell; LT-HSCs, long-term hematopoietic stem cells; CFU, colony forming units; CFU-GM, granulocyte/
macrophage; BM MNCs, bone marrow mononuclear cells; LIC, leukemia-initiating cell
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expression and release ofWNT10B, a hematopoietic stemcell regenerative-associatedmolecule. The establishmentof
a primary AC133+ AML cell culture (A46) demonstrated that leukemia cells synthesize and secrete WNT ligands, in-
creasing the levels of dephosphorylated β-catenin in vivo. We tested the LSC functional activity in AC133+ cells and
found significant levels of engraftment upon transplantation of A46 cells into irradiated Rag2−/−γc−/− mice. Owing
to the link between hematopoietic regeneration and developmental signaling, we transplanted A46 cells into develop-
ing zebrafish. This system revealed the formation of ectopic structures by activating dorsal organizer markers that act
downstream of the WNT pathway. In conclusion, our findings suggest that AC133bright LSCs are promoted by mis-
appropriating homeostatic WNT programs that control hematopoietic regeneration.
Neoplasia (2012) 14, 1236–1248
Introduction
Different genetic causes result in variable clinical courses of acute
myeloid leukemia (AML) and different responses to standard chemo-
therapy including stem cell transplant. Despite the genetic differences
among individual patients, most AML clones display certain common
features. Ample evidence exists in mouse models that AML develops
through the stepwise acquisition of collaborating genetic and epigenetic
changes in self-renewing LICs, which exhibit a committed myeloid
immunophenotype and give rise to nonleukemogenic progeny in a
myeloid-restricted hierarchy [1–3]. An important issue to understand
the early events in the origin of AML is the observation that long-term
hematopoietic stem cell (LT-HSC) expansion precedes the generation
of committed myeloid LICs [4].
Although well-orchestrated cell intrinsic programs and environmental
cues represent the main contributory factors for normal LT-HSC ex-
pansion, it is still unclear if transcriptional programs responsible for the
expansion of premalignant LT-HSC populations and leukemia initiation
share common embryonic or post-embryonic functions, such as stem
cell renewal, tissue repair, and regeneration [5,6]. Even though recent
studies have addressed the role of Hedgehog signaling for maintenance
of cancer stem cells in myeloid leukemia [7], its requirement in AML
remains controversial [8].
Recently, the notion that LICs are restricted only to the CD34+CD38−
population has been challenged [9,10] and it has been suggested that
more cell surface markers could be appropriately used to enrich the
leukemia-initiating cell (LIC)–containing fraction. One of such markers
is the AC133 antigen (a glycosylation-dependent epitope of CD133)
that defines a desirable population of stem and progenitor cells con-
taining in turn all the CD34brightCD38− progenitors, as well as the
CD34brightCD38+ cells committed to the granulocytic/monocytic line-
age [11]. In addition, AC133 represents a well-documented marker of
tumor-initiating cells in a number of human cancers [12]. In this study,
fluorescence-activated cell sorter (FACS) analysis demonstrates that
AC133+ cell population is dramatically expanded in 25 AML cases ana-
lyzed. We carried out genome-wide transcriptional analysis of AC133+
cells isolated from newly diagnosed non-promyelocytic AML patients
(n = 33) and healthy donors (n = 10). Results obtained from a multistep
analysis of the generated data defined the involvement of the ligand-
dependentWNT receptor signaling pathway as the self-renewal associated
signature in the AC133-enriched fraction in human AML. Furthermore,
the results presented here suggested thatWNT10B and otherWNTgenes
expressed during the regenerative process of the hematopoietic system
[13,14] are aberrantly upregulated in AC133bright AML cells. To obtain
a localized detection of each single transcript, we first applied an in situ
detection of individual mRNA molecules [15] on bone marrow (BM)
sections from AML patients. By the establishment of a primary culture
of AC133+ AML cells (termed A46 hereafter), we confirmed that secreted
WNTs activated a β-catenin/human T-cell factor (TCF) transcription–
based reporter construct. Moreover, we intend to clarify the relationship
between the abnormal WNT activation in AC133+ population and the
leukemic stem cell (LSC) activity.UsingRag2−/−γc−/− as immunodeficient
xenotransplantmodel [16], AC133+ A46 cells were injected intravenously
into sublethally irradiated mice.
To achieve a complete view of how AC133+ A46 cells modulated
the microenvironment and given that hematopoietic regeneration
converge to developmental signaling, we used zebrafish embryonic
model as an in vivo biosensor.
Our results confirmed previously reported data [17] and raise new
important implications for the involvement of the ligand-dependent
canonical WNT pathway in AML. These suggestive findings are sup-
ported by the pivotal function of WNT in promoting self-renewal
[18,19], its emerging role in myeloid leukemogenesis [20,21], and
the effects of its constitutive activation through a stabilized form of
β-catenin, by inducing quiescent stem cells to enter the cell cycle and
arresting their differentiation [22,23].
Materials and Methods
Collection of Patient Samples and Normal Hematopoietic Cells
BM MNCs were collected from 33 newly diagnosed, unselected
non-promyelocytic AML patients, according to Niguarda Hospital’s
Ethical Board–approved protocols (116_04/2010). According to the
revised Medical Research Council risk group stratification, based on
cytogenetic and molecular markers/mutations [24], samples included
14 adverse, 13 intermediate, and 6 favorable risk patients. Human
adult BM cells obtained from 10 consenting healthy donors were
processed as previously described [25].
Cell Sorting and Flow Cytometry
We carried out AC133+ cell separation based onMACSMicroBeads
and cytofluorometric determinations, as previously described [25].
Microarray Expression Analysis
Total RNA for expression profiling was extracted using RNAqueous-
4PCR kit (Ambion, Austin, TX) from AC133-selected cells. Expression
profiling was performed on Affymetrix HGU133plus2.0 GeneChip
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arrays according to the manufacturer’s procedures. The bioinformatics
analysis performed in this study was realized using the R language for sta-
tistical computing (http://www.r-project.org/) and the annotation librar-
ies provided by the Bioconductor project (http://www.bioconductor.
org/). Microarray data have been deposited in ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/), with accession number E-MTAB-220.
We performed a genome-wide analysis to select genes differentially ex-
pressed between AML AC133+ patients and AC133+ healthy donors
(Welch t test, 0.05 significance level). The resulting set of differentially
expressed genes has been analyzed for functional enrichment with re-
spect to the terms of the Biological Process (BP) branch of the Gene
Ontology (GO) and the pathways of the KEGG database. We relied
on three different methods for functional enrichment analysis: GOStats
(version 2.12.0 of the Bioconductor package, http://www.bioconductor.
org/packages/release/bioc/html/GOstats.html) [26], Database for Anno-
tation, Visualization and Integrated Discovery (DAVID; http://david.
abcc.ncifcrf.gov/home.jsp) [27], and the iterative procedure of dysregu-
lated pathway analysis proposed by Majeti et al. [17]. The first two tests
are based on the hypergeometric distribution, whereas the last one is
based on a non-parametric test and on an iterative procedure. Over-
represented GO terms and KEGG pathways have been selected at
0.05 significance level.
WNT/β-catenin Responsive Luciferase Assay
HEK293T cells grown in 24-well plates at a density of 1.7 × 105 cells
per well were transfected with M50 Super 8x TOPFlash (plasmid
12456; Addgene, Cambridge, MA) and pRL-TK (Renilla luciferase;
Promega, Madison, WI) using jetPEI (Polyplus, New York, NY). Cells
were treated for 12 hours with A46 conditioned medium (CM) or
HEK293T cells transfectedwithBA-WNT10B (plasmid 1831;Addgene)
CM as positive control. WNT10B expression in HEK293T transfected
with BA-WNT10B was evaluated by SYBR Green–based real-time re-
verse transcription–polymerase chain reaction (RT-PCR) using
WNT10B FW-5′-GCTGTAACCATGACATGGAC-3′ and RW-5′-
CTGCCTGATGTGCCATGAC-3′ specific primers. Luciferase activity
measurement was performed with the Dual-Luciferase Reporter Assay
System (Promega).
Immunoblot
Protein expression was assessed by immunoblot analysis using stan-
dard procedures, applying anti–active β-catenin (ABC) monoclonal
mouse (anti-ABC clone 8E7; Millipore, Billerica, MA), anti–β-catenin
monoclonal rabbit (E247; Abcam, Cambridge, United Kingdom), an-
ti–WNT10B polyclonal rabbit (H-70; Santa Cruz Biotechnology, Inc,
Santa Cruz, CA), anti–WNT10B monoclonal mouse (5A7; Abcam),
anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH) polyclonal
rabbit (ab97626; Abcam), and anti–Pygopus 2 polyclonal rabbit (H-216;
Santa Cruz Biotechnology, Inc) antibodies. Secondary antibodies
used were anti–mouse HRP, anti–goat HRP, and anti–rabbit HRP
(Thermo Fisher Scientific, Waltham, MA).
In Situ mRNA Detection
In situ detection of individual mRNA molecules was performed as
described [15]. One micromolar of locked nucleic acid–modified cDNA
primer (WNT10B, 5′-C+A+G+G+C+CGGACAGCGTCAAGC-
ACACG-3′; β-actin, 5′-C+TG+AC+CC+AT+GCCCACCATCA-
CGCCC-3′; Exiqon, Vedbaek, Denmark) was added to the reverse
transcriptase reaction. Ligation was then carried out with 0.1 μM of
the WNT10B padlock probe or β-actin padlock probe (WNT10B,
5′-[Phos]ACCGTGCCTGTCGGACCCTCCTCTATGATTA-
CTGACCTAAGTCGGAAGTACTACTCTCTTCTTC-
TTTTAGTGAAGCCCAGGCAACCCA-3′; β-actin, 5′-[Phos]
GCCGGCTTCGCGGGCGACGATTCCTCTATGATTACTGA-
CCTATGCGTCTATTTAGTGGAGCCTCTTCTTTA-
CGGCGCCGGCATGTGCAAG-3′; Sigma-Aldrich, St Louis, MO).
Rolling circle products (RCPs) were visualized using 100 nM of detec-
tion probe (WNT10B, 5′-Cy5-AGTCGGAAGTACTACTCTCT-3′
and β-actin, 5′-Cy3-TGCGTCTATTTAGTGGAGCC-3′; Sigma-
Aldrich). Nuclei were counterstained with 100 ng/ml Hoechst 33258
(Sigma-Aldrich). Images of BM tissue slides were acquired using an
Axioplan II epifluorescence microscope (Zeiss, Munchen, Germany)
equipped with a charge-coupled device (CCD) camera (HRM, Zeiss)
and a computer-controlled filter wheel with excitation and emission filters
for visualization of 4′-6-diamidino-2-phenylindole (DAPI), Cy3, and Cy5.
A ×20 objective (Plan-Apocromat, Zeiss) was used for capturing the images.
Images were collected using the Axiovision software (release 4.3, Zeiss).
Images were collected as z-stacks to ensure that all RCPs were imaged, with
a maximum intensity project created in Axiovision. For quantification, the
numbers of RCPs and cell nuclei in images were counted digitally using
CellProfiler software (www.cellprofiler.org) on three ×20 microscope
images. The total number of RCPs was divided by the number of nuclei
for each image. The average for each sample was then calculated from the
result of the three images and is reported as RCPs per cell.
Immunostaining
Direct and indirect immunostaining were performed following stan-
dard procedures. BM biopsies of AML patients, previously embedded in
paraffin blocks, were cut in 5-μm-thick sections and mounted on slides.
Slides were incubated with primary antibody mouse anti-CD133.1
(AC133) (1:100;Miltenyi Biotec GmBH, BergischGladbach, Germany),
directly labeled with 488-nm dye (Sigma), and with primary antibodies
such as mouse anti-ABC (1:100; Millipore), rabbit anti-WNT10B
(H70) (1:100; Santa Cruz Biotechnology, Inc), rabbit anti–Pygopus
2 (H-216) (1:100; Santa Cruz Biotechnology, Inc), goat anti-SMYD3
(F-19) (1:100; Santa Cruz Biotechnology, Inc). Samples were incubated
with the secondary antibodies donkey anti-mouse Alexa Fluor 488
(1:500; Life Technologies, Carlsband, CA), donkey anti-rabbit Alexa
Fluor 568 (1:500; Life Technologies), and donkey anti-goat Alexa Fluor
568 (1:500; Life technologies). Nuclei were counterstained with 100 ng/ml
DAPI (Sigma-Aldrich). Cells were analyzed using the upright micro-
scope (Leica, DM 4000B).
Immunofluorescence Image Analysis
Image analysis was performed bymeans of a custom automatic routine
and the ImageJ program (1.43s; National Institutes of Health, Bethesda,
MD). Maps of ABC+/WNT10B+ cells were obtained using an auto-
matic threshold based on moments algorithm newly implemented in
the ImageJ program and mathematical morphology plugin developed
by D. Prodanov (http://rsbweb.nih.gov/ij/plugins/gray-morphology.
html). DAPI staining was used to identify nuclei. Finally, images of
nuclei for positive cells were obtained by Boolean AND operations be-
tween DAPI staining and cell maps. The resulting images were used to
determine the percentage of ABC+/WNT10B+ cells both manually or
through the Analyze Particles function of ImageJ.
Cell Culture
Selected AC133+ cells from BM at AML diagnosis were cultured
for 16 weeks. The culture was performed using synthetic medium
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StemSpam H3000 (StemCell Technologies, Vancouver, Canada) in
the absence of serum and cytokines. StemSpan H3000 and HPGM
media, conditioned by the cell culture, were collected after 12 weeks,
refined with 0.2-μm filter and stored at −20°C. HEK293T cells
were grown in Dulbecco’s modified Eagle’s medium (high glucose
with sodium pyruvate and L-glutamine; Euroclone), supplemented
with 10% FBS (Euroclone) and penicillin-streptomycin solution
(100×) (Euroclone, Milano, Italy).
Mice and Xenogeneic Transplantation
Rag2−/−γc−/− BALB/c mice were bred and maintained under specific
pathogen-free conditions in the mouse facility of Istituto Oncologico
Veneto, and experiments were performed according to state guidelines
and approved by the local ethics committee. Rag2−/−γc−/− mice at
6 weeks were sublethally irradiated with 5 Gy and transplanted via the
tail vein with 1 × 106 of human AC133+ AML cells (A46).
Evaluation of Hematopoietic Chimerism by Flow Cytometry
Three weeks after transplantation, recipient mice were sacrificed and
BM cells were harvested by flushing femurs and tibias. BM engraftment
was evaluated using human antibodies CD34, CD38, AC133, and
CD45 [BD Biosciences (Bedford, MA) and Miltenyi Biotec GmBH].
Multicolor flow cytometric analyses were performed using FACSCalibur
flow cytometer (BD Biosciences) and analyzed by FlowJo software (Tree
Star, Ashland, OR). Cell engraftment was determined by expression of
the human panleukocyte marker CD45.
Zebrafish Models and Transplantation Procedures
Embryos were handled according to relevant guidelines. Fish of the
AB strain were maintained at 28°C on a 14-hour light/10-hour dark
cycle and collected by natural spawning. Transplantation of human
A46 cells into zebrafish embryos was performed as previously reported
[28]. Briefly, fluorescently labeled A46 cells were resuspended in 1×
phosphate-buffered saline and injected into zebrafish blastulae (be-
tween 100 and 200 cells per injection) at 3 hours post-fertilization
(hpf ). Injected live embryos were observed under a fluorescent micro-
scope at 30% of epiboly to ensure the presence of labeled A46 cells.
Embryos were collected at the desired developmental stages, immediately
fixed, and processed for whole-mount in situ hybridization according
to Thisse et al. [29], using gsc, ntl, and pax2a DIG-labeled riboprobes.
Results
AC133+ Cells Are Highly Expanded in AML
AC133 antigen is restricted to a rare cell population with long-term
reconstituting activity, ranging from 20% to 60% of all CD34+ cells,
and resulting barely detectable in CD34−Lin− cells [11–30]. We have
previously shown that AC133+ LT-HSCs are also highly enriched in
colony forming units and have a stronger granulocyte/macrophage
differentiation potential relative to unselected BM MNCs. However,
their burst-forming units–erythroid forming potential is lower [25]. To
determine the range of expansion of AC133+ cell fraction in AML, flow
cytometric quantification of CD133.1 (AC133) expression either in
single staining or in combination with the pan-hematopoietic marker
CD45 was performed in BM on 25 primary non-promyelocytic AML
samples and 10 age-matched healthy volunteer adult donors. The re-
sulting CD133.1+ cell fraction results expanded among AML patients
by a median of 31.5% [interquartile range (IQR), 16.5%–53.4%] with
respect to normal donors (median, 0.54%; IQR, 0.17%–1.14%; P <
.0001; Figure 1, A–C). To directly compare the gene expression profiles
of purified populations highly enriched in LSCs or HSCs, positive selec-
tion of CD133.1+ cells was performed on all the 33 non-promyelocytic
AML patients (25 de novo, 7 secondary to myelodysplasia, and 1 second-
ary therapy-related; Table W1) as well as on the 10 healthy donors
recruited to this study, respectively. MNC selection in samples from
AML patients led to an average of 236-fold enrichment of AC133-
positive cells (IQR, 142.72–419.44, data not shown).
Identification of Dysregulated Pathways in AC133+ AML
Cell Fraction
To identify the dysregulated pathways in AC133+ AML cell frac-
tion versus normal long-term reconstituting AC133+ HSC cells, we
performed a genome-wide functional enrichment analysis on gene ex-
pression microarray data of 33 AML patients and 10 healthy donors.
The identification of overrepresented pathways in AC133+ AML cells
was realized through three computational tools: GOStats [26], DAVID
[27], and dysregulated pathway analysis according to Majeti et al. [17].
Employing the functional terms from GO BPs and the pathway infor-
mation from KEGG databases, we found 212 functionally enriched
GOBP terms with GOStats (P < .01), 284 GOBP terms with DAVID
(P < .05), and 616 GO BP terms with the non-parametric test of
Majeti et al. (P < .05). Moreover, GOStats selected 16 KEGG pathways
Figure 1. Human AC133+ cells are strongly expanded in AML. Representative dot plots of the immunophenotype analysis from the BM of
(A) a healthy donor and (B) a patient with AML (AML No. 42 in Table W1). The CD45/CD133.1 co-staining was gated on BMMNCs; percent-
ages on total cellularity are shown for gated normal and AML populations. (C) Flow cytometry analysis of the CD133.1 antigen in BMMNCs
of healthy donors (n=10) and AML patients (n=25). The IQR for each sample group is indicated in the dot. Mann-WhitneyU test was used
to calculate the P value (α = 0.001).
Neoplasia Vol. 14, No. 12, 2012 Regenerative WNT Signaling Activated in AC133+ Beghini et al. 1239
Figure 2. Schematic visualization of dysregulated networks in KEGG database and representation of WNT gene expression profiles.
(A) Visualization of WNT signaling pathway in the KEGG database. Highlighted genes are differentially expressed and red-starred path-
ways are overrepresented in AC133+ AML cells. (B) Heat map of the differentially expressed WNT-associated genes. The color bar under
the patient sample dendrogram identifies AML samples (red) and healthy controls (blue). The names, accession numbers, as well as
P values for the differentially overexpressed and underexpressed genes are shown in the right panels.
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(P < .05), DAVID selected 24 KEGG pathways (P < .05), and the
dysregulated pathway analysis selected 3 KEGG pathways (P < .05).
As shown in Table W2, DAVID ranks the WNT signaling pathway
(P = .022) among the first 10 dysregulated pathways in AC133+
AML cells. The visualization of the WNT molecular interaction in
KEGG database is presented in Figure 2A.
It is worth noting that different statistical methods agree in identify-
ing theWNT pathway as a significant dysregulated pathway in AC133+
AML cells. Moreover, the WNT signaling pathway in KEGG is se-
lected as overrepresented in AC133+ AML stem cells by both GOStats
and DAVID. Taken together, the functional enrichment methods
select the term “WNT receptor signaling pathway” (GO:0016055)
as the most specific self-renewal associated dysregulated pathway.
WNT Gene Expression Profiles of Normal and Leukemia
Long-term Reconstituting AC133+ Cells
To obtain insights into theWNTpathway in AC133+ leukemia cells,
we focused our analysis on the probe sets annotated to “WNT receptor
signaling pathway” GO class or to any of its children GO terms. The
resulting probe set list was complemented with the probes mapping to
genes in a manually curated list of WNT target genes and with probes
mapping to other well-known WNT genes, not included in the previ-
ous two lists. The total list of analyzed WNT genes includes 480 probe
sets, mapping to 193 different genes (Table_A in http://homes.dsi.
unimi.it/~re/TRdataset/). To assess differential expression of WNT
genes, we employed Welch t tests (two-tailed) on the 480 probe sets,
thus identifying 103 differentially expressed genes (P < .05; Figure 2B).
Genes shown to be highly AML-specific include the WNT ligands
WNT2B, WNT6, WNT10A, and WNT10B [14], the WNT/β-catenin
signaling agonists including SMYD3 [31], DKK2 [32], SOX4 [33],
PROP-1 [34], and PYGO2 [35,36], antagonists including WIF-1
[37], KLHL12 [38], LRP6 [39], KREMEN1 [40], E2F1 [41], DACT1
[42], and HBP1 [43], and the deregulated WNT targets including
STAT3, MYCN, ABCC4, DLX3, MARK4, RUNX2, CD24, and
CD44 [44]. Collectively, these data are consistent with ligand-dependent
activation of the regeneration-associated WNT pathway [14].
We also investigated whether the expression of the WNT genes
varied between the risk groups in AML (favorable, intermediate, and
adverse) revised by Smith et al. [24]. Clustering results of AML cases
restricted to WNT genes show that the risk groups are not clearly
distinguishable in separate clusters (Figure 2B). Analysis of variance
between groups confirms these results: only 3 (ABCC4, HBP1, and
NDP) of 193 WNT-related genes are differentially expressed across
the three categories (P < .05). Thus, our data do not support a signif-
icant distinction between risk groups in AML patients. This state-
ment should be considered with caution, because the cardinality
of the subgroups is relatively low (6 favorable, 13 intermediate, and
14 adverse samples).
Hyperactive WNT Signaling Resulted Activated in
Diffuse AC133bright AML Cells Expressing the
Hematopoietic Regenerative Molecule WNT10B
Most of what is known about hematopoietic regeneration point to
WNT signaling pathway and specifically toWNT10B [13,45]; therefore,
Figure 3. Altered WNT signaling in AC133+ AML cells. (A) Detection with padlock probe and target-primed rolling circle amplification of
individual WNT10B transcripts on BM slides from AML patients. Green RCPs represent WNT10B transcripts, and red RCPs represent
β-actin transcripts in consecutive sections. Cell nuclei are shown in blue. Images were acquired with ×20 magnification. Scale bar, 10 μm.
(B) The quantification of RCPs was done on three ×20 images of BM biopsies of AML patients. For quantification, the numbers of RCPs
of each image were counted digitally using CellProfiler software. The average of RCPs for each sample was calculated and it is reported as
a ratio between β-actin and WNT RCPs. (C) Immunoblot analysis of ABC, β-catenin (as detected with the N-terminal pan–β-catenin antibody),
WNT10B, and Pygopus 2 protein expression in AC133+ cell fractions from 18 patient samples and 1 healthy donor introduced as control.
GAPDH, loading control. HD, healthy donor; *therapy-related secondary AML.
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we investigated how expression of WNT10B is related to AML
phenotype. To fully understand mRNA distribution of WNT10B
within BM sections, we focused on the application of single molecule
detection methods. In situ mRNA detection by target-primed rolling
circle amplification analysis offers high sensitivity and localized detec-
tion within single cells and tissues [15]. Following this approach, we
detected WNT10B-related transcript in BM sections obtained at diag-
nosis from two randomly selected patients. β-Actin was included as a
reference transcript in consecutive sections. Visualization by using high-
performance fluorescence microscopy showed a diffuse localization
pattern in the tissues (Figure 3A). Signal distribution and RCP quantifi-
cation showed a β-actin/WNT10B ratio close to 1, suggesting a con-
stitutive activation of WNT10B transcription in the BM (Figure 3B).
In addition, we analyzed transcriptional activation of canonical WNTs
focusing on genes that have been shown to be potent regulators of stem
cell functions. N-terminally dephosphorylated β-catenin (ABC) was
increasingly accumulated as determined by immunoblot analysis (Fig-
ure 3C). Remarkably, we confirmed a dramatic increase in WNT10B
expression in all patient samples, except for one, reanalyzed by immuno-
blot (Figure 3C). Interestingly, the only AML patient negative for the
WNT10B expression (AML No. 40 in Table W1) was affected by
therapy-related AML. According to the biologic relevance of PYGO2
in promoting the responsiveness ofWNT signaling [35,36], diffuse over-
expression was detected by immunoblot (Figure 3C). To better elucidate
the impact of the broad WNT10B overexpression on the leukemic
microenvironment, we examined its expression in histologic preparations
of BM from five randomly selected AML patients at diagnosis. Double
immunostaining for WNT10B and ABC, followed by ImageJ analysis,
confirmed that WNT10B was expressed by a high proportion of leuke-
mic cells.We next examined by immunostaining a number of BMbiopsy
sections from five randomly selected cases. In all the analyzed samples,
the AC133 immunostaining revealed islands of highly positive cells
(AC133bright) in an estimated proportion of 8% of cells, amid AC133dim
or negative tumor blasts (Figure 4A). AC133bright cells correlated with
accumulation of ABC (Figure 4, B and C). WNT10B antibody staining
was also detectable in interstitial spaces, suggesting its secretion and re-
lease in the BMmicroenvironment (Figure 4D, top). The slides revealed
thatWNT10B is diffusely expressed (Figure 4,A andD) but that only the
AC133bright small cells (8–10 μm diameter of the nuclei), with a clonal
appearance and increased N/C ratio, shared the WNT signaling activa-
tion signature represented by accumulation of ABC [46], likely induced
through an autocrine/paracrine mechanism (Figure 4, B and D, top).
AC133+ Leukemic Cells Express and Secrete WNT10B
in a Primary Cell Culture
The notion that primary cell cultures closely mimic the in vivo state
and generate more physiologically relevant data led us to establish a
primary AC133+ cell culture (A46). A46 cells, with diploid karyotype,
were selected from a 66-year-old male at diagnosis of AML-M2 (AML
No. 46 in Table W1). Immunophenotype of MNCs before selection
revealed a dominant CD133.1+CD34+CD38−CD45+CD117+ blast
population (59%; Figure 5A), representing an optimal source to establish
an LIC-enriched primary culture. Recently published data implicate the
existence of an immunophenotypic hierarchy in AML, with a minority
of CD38−CD45+ cells giving rise to CD38+CD45+ “GMP-like” cells
at the apex of an LIC hierarchy [10]. The latter finding seems to suggest
that CD38−CD45+ cells start to gain CD38 expression after AC133 se-
lection procedures as observed in sorted cells (Figure 5A). Comparative
analysis of spotted AC133-selected A46 leukemic and normal cells by
Figure 4. β-Catenin activation in the subpopulation of AC133bright
AML cells expressing WNT10B. (A) Representative immunostaining
micrographs show green fluorescence of cells expressing AC133 in
a BM section of AML No. 9 (TableW1). Cell nuclei are shown in blue.
Scale bar represents 10 μm. (B) Co-staining of BM from AML No. 9
adjacent serial section for expression of ABC (green) and WNT10B
(red). Cell nuclei are shown in blue (DAPI). (C) False color maps of
ABC/WNT10B double positive cells (blue) were obtained using an
automatic threshold based on the moments algorithm implemented
in the ImageJ program. DAPI staining was used to identify nuclei.
Images obtained crossing ABC masks with WNT10B signals were
used to count the percentage of ABC/WNT10B double positive cells
over the total number of cells. The macro was validated against
a trained experimenter over a sample of 830 total cells from eight
different images. Differences in results were restricted to less than
0.01%. (D) Morphologic detail of cells showing intense specific
staining for ABC (top panels) and WNT10B (bottom panels). All
images were acquired with a ×40 objective. Scale bars represent
10 μm. Representative images of at least three serial slides from
five randomly selected patients.
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Figure 5. AC133+ A46 cells express and release WNT10B. Dot plots of the immunophenotype analysis from AML No. 46 BM MNCs at
diagnosis and after selection. (A) Patterns of CD38/CD133.1 (top left), CD117/CD45 (top right), and CD34/CD38 (bottom left) co-stainingwere
gated on BM AML cells before selection. Representative CD34 and CD38 expression on Ficoll-selected MNCs (bottom center) and AC133-
sorted cells before culture (bottom right) is shown. Percentages on total cellularity are shown for gated AML populations. (B) Immuno-
staining assessment for WNT10B in AC133+ populations from A46 (top panels) or healthy donor (bottom panels). Representative images
of at least five serial slides. Blue, nuclei; red, WNT10B; merge, WNT10B/DAPI. All images were acquired with a ×40 objective. Scale bars
represent 10 μm. (C and D) TOPFlash reporter assay showing luciferase expression driven by eight TCF/lymphoid-enhancing factor (LEF)
binding sites. (C) Positive control was obtained by CM of pBA-WNT10B–transfected H293T cells. Expression of WNT10B was evaluated
in pBA-WNT10B–transfected H293T by real-time PCR (left). TOPFlash reporter assay shows luciferase expression induced in Super
8x TOPFlash–H293T cells by pBA–WNT10B H293T CM (right). (D) TOPFlash reporter assay showing dose-dependent luciferase expression
induced in Super 8x TOPFlash–H293T cells by A46 CM. Significance was evaluated by the unpaired Student’s t test: *P < .05; **P < .001.
Data represent the mean ± SD of triplicate reactions and are representative of three independent experiments.
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immunostaining revealed WNT10B expression in all A46 AC133+ cells
(Figure 5B, top), whereas normal BM-derived AC133+ cells resulted
negative (Figure 5B, bottom). To further investigate whether the endoge-
nous WNT production had any paracrine effect, we used A46 CM
to evaluate β-catenin–mediated transcriptional activation. To this
aim, HEK293T cells (H293T), transfected with Super 8x TOPFlash
β-catenin/TCF transcription–based reporter construct, were exposed
either to pBA–WNT10B H293T CM as control (Figure 5C) or A46
CM. This construct could be efficiently expressed in a dose-dependent
manner when transiently exposed to A46 CM for 12 hours (Figure 5D).
AC133 Is Expressed on Functional A46 AML LSC
To complement the in vitro observations, we tested whether AC133
was expressed on functional A46 AML LSC. We transplanted A46
cells into sublethally irradiated (5 Gy) 6-week-old Rag2−/−γc−/− mice via
the tail vein. This highly immunodeficient mouse strain lacks mature B,
T, and natural killer (NK) cells, supporting efficient engraftment of
human AML [16]. Transplanted mice were killed at 3 to 8 weeks after
transplantation and analyzed for engraftment of human leukemia cells
in BM (Figure 6A). The results of a typical experiment from three
transplanted mice (M1–M3) are shown in Figure 6, with AC133+
A46 cells showing engraftment of human CD45 (hCD45) cells. We
confirmed that engrafted hCD45+ cells were human myeloid leukemia
blasts by measuring CD34/CD38/CD133 expression (Figure 6B).
Transplantation of A46 Induces Ectopic Axial
Structure Formation in Zebrafish Embryo by WNT
Signaling Activation
To bring our functional analyses full circle, we explored the physio-
logical relevance of tumor-derived WNT signals by using the develop-
ing zebrafish as a biosensor. We hypothesized that WNT-secreting
A46 cells transplanted into developing zebrafish embryos might act as
Figure 6. AC133+ A46 cell transplantation in Rag2−/−γc−/−mice. (A) Overview of the experimental design: 1× 106 AC133+ A46 cells were
injected into sublethally irradiated Rag2−/−γc−/−mice through the tail vein. Three weeks after transplantation, BM cells were collected and
analyzed by flow cytometry. (B) Expression profiles of three recipient mice (M1–M3) are shown. hCD45+ population was identified in BMs of
mice, and within hCD45+, the expression patterns of hCD34 and hCD133.1 (AC133) were analyzed. Cells were separated in subpopulations
according to the expression of hCD34 and hCD133.1 and then analyzed for hCD38 and hCD133.1 expressions.
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ectopic sources of maternal WNT ligands. Cell-grafted embryos,
injected at or before the mid-blastula transition stage (∼3 hpf) with
Hoechst 33342 fluorescently labeled A46 cells (Figure 7A), showed
the expression of the organizer-specific gene goosecoid (gsc). Expression
of gsc is typically initiated by the nuclear translocation of maternal
β-catenin triggered by the activation of the WNT signaling. While
normal AC133+ cells did not alter the normal expression of the gene
(Figure 7B), approximately 30% of the embryos grafted with A46 cells
(n = 208) displayed both the expansion of the gsc endogenous domain
and the activation of the gene in ectopic positions (Figure 7, C and D).
Consistent with our hypothesis, the A46 cells retain a dorsal organizer–
inducing activity possibly correlated with their strong WNT signaling
activation. In addition, grafted embryos developed secondary axial struc-
tures, ranging from additional tail tissues (Figure 7, E–H) to an almost
fully formed ectopic head (Figure 7I ). Control embryos grafted with
normal BM-derived AC133+ cells, devoid of any WNT signaling ac-
tivity, did not display alterations of the normal phenotype (data not
shown). The identity of the additional tail structures was confirmed
by in situ hybridization staining for the notochord and tail bud marker
ntl [47], whereas the emergence of ectopic head structures was high-
lighted by pax2a labeling optic stalk, midbrain–hindbrain boundary,
and otic vesicles. These results imply that A46 cells might determine
the establishment of an additional source of signal, with a Nieuwkoop
center–like activity, able to induce an extra dorsal organizer, similarly
to the endogenous situation at mid-blastula transition, when maternal
WNT/β-catenin signaling initiates the formation of the dorsal orga-
nizer [48]. In zebrafish, secondary axis can be also induced by Nodal,
a highly evolutionarily conserved morphogen belonging to the trans-
forming growth factor–β superfamily and able to activate gsc expression
[49]. Therefore, we investigated the possible involvement of the Nodal
signaling pathway in the dorsal organizer induction mediated by A46
cells. The complete lack of Nodal expression observed after microarray
analyses was confirmed by qualitative RT-PCR in A46 and samples
from six different AML patients (Figure W1), allowing to exclude any
Nodal contribution from A46 cells to the formation of the secondary
axis and induction of gsc expression.
Discussion
The deceivingly homogeneous, undifferentiated morphology of the
AML blasts is now known to mask a heterogeneous collection of cells
that recapitulate the hierarchy of precursor cells that characterize the
normal process of blood-cell differentiation. The concept that LIC
properties occur in a self-renewing non-HSC progenitor cell popula-
tion, preceded by the expansion of a preleukemic LT-HSC, has been
recently reinforced [4,10]. However, the molecular functions respon-
sible for the preleukemic LT-HSC expansion and the acquisition of
self-renewal ability in AML remained poorly defined.
The WNT/β-catenin pathway has been show to play a critical role
in the regulation of cell proliferation, differentiation, and apoptosis of
different malignant entities. It is highly regulated in AML [50] and
also involved in the self-renewal process of HSCs. WNT/β-catenin
pathway requirement for LIC development in AML has emerged
in mouse model [21]. Recent studies revealed aberrant WNT signal-
ing in AML cells that is independent from the occurrence of AML-
associated fusion proteins or mutations in tyrosine kinase receptors
[reviewed in 20].
The results presented here using gene expression microarrays and
pathway analysis provide direct evidence that the WNT/β-catenin sig-
naling is diffusely activated in the AC133+ AML population, with a spe-
cific transcriptional signature involving overexpression of the WNT
pathway agonists and down-modulation of the major antagonists.
Although the long-term reconstituting human HSC marker AC133
has been detected in a majority of CD34+ AML [51], no extensive data
concerning the role of AC133 in AML were available.
Analysis of freshly fractionated cells from AML patients showed that
active WNT signaling was predominant in the population highly en-
riched for the AC133 marker. Notably, WNT2B, WNT6, WNT10A,
and WNT10B, known to promote hematopoietic tissue regeneration
[13,14], are the WNT mediators specifically upregulated in the AC133+
Figure 7. A46AML cells induce ectopic gene expression and second-
ary body axis formation upon transplantation in zebrafish embryos.
(A) Fluorescence microscopy of a live zebrafish embryo at 30% of
epiboly (lateral view) transplanted at 3 hpf at the animal pole region
with A46 cells previously blue-stained with Hoechst 33342. (B–D)
Dorsal side view of 70% epiboly-stage embryos hybridized with
a gsc-specific probe. Embryos have been injected with (B) normal
AC133+ cells as control or (C and D) A46 AML cells. The arrow-
heads indicate the gsc endogenous signal, while arrows specify
the position of zebrafish cells expressing ectopic gsc. (E) Bright-field
microscopy of a 24-hpf zebrafish embryo injected with A46 AML
cells (lateral view). The arrowhead and the dotted line indicate the
secondary trunk/tail induced by A46 cells. (F, G) The embryo in E
has been hybridized with a probe specific for the notochord and tail
bud marker ntl. (F) The probe labels the notochord (n) in the endoge-
nous trunk and the chordoneural hinge (cnh) in both tails (G, higher
magnification). (H) Tail of a 24-hpf embryo hybridized with ntl-
specific probe. The endogenous (n) and ectopic (*n) ntl signals run
parallel along the axis of the embryo, indicating the presence of
additional axial structures. (I) Dorsal view of a 24-hpf embryo that de-
veloped an ectopic head on the side of the endogenous one, as indi-
cated by the expression of the brain marker gene pax2a. The dotted
lines indicate the main (M) and secondary (S) axes. The optic stalk
(OS) in close vicinity to the eye (e), the midbrain-hindbrain boundary
(MHB), and the otic vesicles (OV) of the embryo are stained with the
pax2a riboprobe, as well as several areas of the ectopic head (the
asterisks indicate the twoclearly recognizable additional otic vesicles).
The image is composed of different pictures corresponding to several
focal planes, since the embryo is not flat, and a single focal plane
cannot comprise all the labeled structures belonging to the main
and secondary axes. Scale bars represent 125 μm (A–D), 150 μm
(E), 40 μm (F), 15 μm (G and I), or 25 μm (H).
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AML cells. In addition, there is evidence that in the hematopoietic
system WNT10B is specifically and significantly upregulated following
an injury and that WNT10B acts to enhance the growth of HSCs [13].
It is also worth noting that greater fold expansion of murine HSC
progenitors was obtained after WNT10B CM exposure [52]. Consis-
tent with the latter observations, we showed a dramatic increase of
WNT10B expression and protein release within the microenviron-
ment in the large majority of samples from AML patients recruited
to this study, with the exception of the unique therapy-related AML
patient. In accordance with previous reports [52], we have not detected
WNT10B gene expression in normal AC133+ hematopoietic cells.
Moreover, our data also point to the strong expression of the WNT
target gene CD44 and the loss of CD24, according to the expression
of CD44+CD24−AC133+ phenotype that defines a putative cancer
stem cell population also in breast tumors [53]. Interestingly, Dick
et al. have shown that CD44 is a key regulator of AML LSC func-
tion and that targeting it eradicates LSCs [54]. In light of the higher
homeostatic range of WNT/β-catenin signaling occurring upon an acute
injury [55], our study demonstrated the involvement of the regeneration-
associated WNT signaling in AC133bright AML cell fraction. The term
“regeneration” has been used to define the physiological phenomena of
reconstitution from damage due to injury or disease. Hematopoietic
regenerative-associated WNT ligand (WNT10B) is expressed at mRNA
and protein levels on both leukemic blasts and stromal-like cells, indi-
cating a possible autocrine/paracrine involvement of WNT in the BM
microenvironment. Conversely, activation of WNT signaling marked
by expression of the dephosphorylated β-catenin was restricted to the
smaller population of AC133bright leukemic cells. The reasons for these
differences are unclear, but it is possible that β-catenin activation by
WNTs requires the expression of specific Fzd receptors, conferring a
“responsive” phenotype, only restricted to a rare population of cells. In
the HSC biology, a fundamental question is how self-renewal is con-
trolled; several lines of evidence point to Notch for a WNT-mediated
maintenance of undifferentiated HSCs [56]. Recent studies, examining
the molecular targets of WNT10B, have highlighted the nuclear factor
κB and Notch pathways as downstream targets of WNT10B [57]. It is
tempting to speculate that WNT10B and other regeneration-associated
WNTs (i.e., WNT2B, WNT6, and WNT10A) integrate with other
signals, such as Notch, to drive oncogenic renewal. Because activation
of WNT signaling can increase the ability of HSCs to reconstitute the
hematopoietic system of lethally irradiated mice, we transplanted the
AC133+ A46 cells into irradiated Rag2−/−γc−/− mice. Different papers
have been recently published in which comparisons in the engraftment
ability of different immunodeficient murine models were made. The
variability of the reconstitution seemed to be mainly linked to the degree
of immunodepression of the murine host. Rag2−/−γc−/− represents a
powerful model to verify the biologic and malignant characteristics of
human tumor cells. It is characterized by immunodeficiency of T and
B cells caused by Rag2 knockout, coupled with the NK deficit mediated
by the absence of the γc interleukin receptor chain [16]. The results of our
experiments indicate that AC133 is expressed on AML LSC in the A46
primary cells, suggesting that regeneration-associated WNT expression
signature is enriched in primary human AML LSC–containing fraction.
Regeneration requires the rapid expansions of HSCs; this process
is often mediated by reactivation of developmental signal transduction
pathways, such as BMP and WNT [45,58]. In the early embryo, the
WNT factors induce the nuclear translocation of β-catenin, which trig-
gers the formation of the dorsal organizer through the activation of
zygotic dorsal-specific genes [59]. SuchWNT-induced cascade of events
results in the establishment of the embryonic dorsoventral axis [47]. To
test the hypothesis that regeneration-associated WNT signaling is in-
volved in AML LSC expansion, we used a zebrafish embryonic model
as a tool by examining the ability of A46 primary leukemia cells to
modulate embryonic microenvironment. Therefore, we used zebrafish
embryos to show that A46 cells prompt secondary axis development,
inducing the formation of a dorsal organizer–like structure, possibly
through the secretion of different WNT ligands. The mechanisms pro-
moting organizer formation are known to involve cooperation between
Nodal andWNT signaling. However, implanted cell lines with different
origin induce the dorsal organizer independently from the Nodal sig-
naling [60]. Here, we demonstrated that the A46-dependent alteration
of zebrafish development and activation of the organizer-specific gene gsc
are not reliant on Nodal activity.
In summary, the findings we report here implicate, for the first time,
that regeneration-associated ligand-dependent WNT signaling exceeds
the homeostatic range in the majority of human AML cases and affects
responsive AC133bright cells whose renewal is promoted byWNT path-
way activity in vivo. These results not only support that AC133 is ex-
pressed on functional leukemia stem cells, but because developmental
signal transduction pathways are often reactivated during regeneration,
we also show that AC133+ AML cells induce the formation of a dorsal
organizer–like structure in zebrafish embryos.
Finally, these studies suggest that the regenerative WNT signaling
is a stem cell–associated function altered, as a common feature, in
AC133bright AML leukemia stem cell fraction. Future studies will be
required to demonstrate a pathogenic association of AC133bright LSC
regeneration response with AML, in terms of tumorigenicity, clinico-
pathologic features, and patient outcomes.
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Table W1. Clinical Characteristics and Outcome of AML Patients.
No. Age, y/Sex FAB Cytogenetics* FLT3 NPM1 WBC, ×109/L MO Blast, % EML s-AML Response to Induction Relapse Outcome
1 67/M M2 45,XY,−7 wt – 1.7 55 Absent Yes† CR Yes D/first res rel
2 45/M M1 Complex karyotype wt – 1.7 60 Absent No CR No A/first CR
4 59/M M4 46,XY,del(20)(q11;q13) wt – 3.5 32 Absent No CR No A/first CR
5 47/F M4 46,XX ITD – 84.6 80 Skin No CR No A/first CR
6 76/F M4 47,XX,+11 wt – – – Absent Yes† ref dis n.a. D/prim ref dis
9 20/M M0 46,XY wt – 3.6 80 Absent No CR Yes A/second CR
10 62/F M5a 46,XX wt – 69 90 Skin No CR No A/first CR
13 57/M M1 46,XY,t(6;9)(p23;q34) ITD wt 39.7 89 Absent No ref dis n.a. D/prim ref dis
14 72/F M2 46,XX wt – – – Absent No ref dis n.a. D/prim ref dis
16 41/F M2 46,XX wt wt 15.9 45 Absent No CR No A/first CR
17 29/M M1 46,XY ITD wt 217.7 96 Absent No CR Yes D/first res rel
19 29/F M1 46,XX,del(11)(q23) wt – 110.6 95 Skin No ref dis Yes D/first res rel
21 22/M M1 46,XY ITD wt 16.7 75 Absent No CR No A/first CR
23 65/M M1 46,XY wt wt 12.7 78 Absent No CR Yes A/second CR
24 59/M M1 46,XY wt Exon 12 20.1 75 Absent No CR Yes A/first rel
25 39/F M1 46,XX,del(11)(q23) wt wt 15.7 – Absent No ref dis n.a. D/prim ref dis
30 41/M M5a 46,XY wt wt 3.6 75 Absent No CR Yes A/first rel
32 52/F M2 46,XX wt wt 2.7 55 Absent Yes† CR No D/TRM first CR
34 29/M M0 46,XY,del(11)(q13;q23) wt wt 4 86 Absent No CR Yes D/first res rel
38 59/F M1 46,XX wt Exon 12 1 82 Absent No CR Yes D/first res rel
39 51/M n.a. Complex karyotype wt wt 1.2 – Absent No ref dis n.a. D/prim ref dis
40 55/F M2 Complex karyotype wt wt 0.8 20 Absent Yes‡ n.a. n.a. A/active dis
41 62/F M4 46,XX wt wt 17 30 Skin Yes† CR Yes A/first res rel
42 65/F M4 46,XX wt wt 1.2 60 Adnexal mass No ref dis n.a. A/prim ref dis
44 56/F M2 46,XX,t(8;21)(q22;q22) wt wt 8.6 65 Absent No CR Yes A/second rel
46 66/M M2 46,XY ITD wt 26.8 80 Absent No PR n.a. A/prim ref dis
47 62/F M2 47,XX,+21 wt Exon 12 23 12 Absent Yes† n.a. n.a. A/active dis
48 43/M M5a 46,XY ITD Exon 12 63.9 85 Absent No CR Yes A/second CR
49 68/F biphen. 45,XX,−7,t(9;22)(q34;q11) wt wt 8.1 70 Absent No CR Yes A/second CR
50 61/F M4 Complex karyotype wt wt 8.8 35 Absent No ref dis n.a. D/prim ref dis
51 15/F M5b 46,XX wt wt 118 84 CNS No CR Yes D/first res rel
52 33/M M2 46,XY wt Exon 12 20.9 40 Absent No CR No A/first CR
53 51/F M1 46,XX wt Exon 12 81.1 77 Absent No CR No A/first CR
A, alive; CR, complete remission; PR, partial remission; D, dead; ref dis, refractory disease; res rel, resistant relapse; biphen, biphenotypic; TRM, transplant-related mortality; s-AML, secondary AML;
EML, extramedullary leukemia; n.a., not applicable.
*At diagnosis.
†Myelodysplastic AML.
‡Therapy-related AML.
Table W2. Top 10 Dysregulated KEGG Pathways in AC133+ AML Cells.
Term No. of Genes P
Oxidative phosphorylation 78 9.9 × 10−7
Focal adhesion 107 7.0 × 10−3
Neurotrophin signaling pathway 70 7.3 × 10−3
Ribosome 51 1.0 × 10−2
Calcium signaling pathway 94 1.1 × 10−2
Adherens junction 45 1.3 × 10−2
Long-term potentiation 40 1.6 × 10−2
Axon guidance 71 1.9 × 10−2
WNT signaling pathway 80 2.2 × 10−2
Ubiquitin-mediated proteolysis 73 2.3 × 10−3
No. of genes is referred to KEGG pathway.
P is obtained through the modified Fisher exact test (EASE score in DAVID).
Figure W1. Nodal expression analysis on BM samples from AML patients. RT-PCR analysis has been performed to investigate the level of
Nodal expression in AML samples from six different patients (lanes 1 to 6). The analysis has also been performed on BM specimen sampled
from a healthy donor (lane HD), and monitored for quality with a positive control (lane HS401, human embryonic stem cell line HS401) and a
no cDNA negative control (lane neg). A 100-bp molecular weight DNA ladder (Genespin) has been loaded onto the gel for amplicon sizing
(lane L). The analysis pointed out the complete lack ofNodal expression in all the six samples tested, aswell as, unsurprisingly, in the healthy
donor. Arrowhead indicates the size of the Nodal-specific PCR product (392 bp) obtained with the following pair of primers: HuNODAL_ff2:
5′AGGGCGAGTGTCCTAATCCT and HuNODAL_rr: 5′CAGACTCCACTGAGCCCTTC. To further increase the sensitivity of the assay, we have
subjected the PCRs to a second round of amplification using a semi-nested approach with the same reverse primer and with a nested
forward primer (HuNODAL_ff1: 5′GAGGAGTTTCATCCGACCAA). The semi-nested PCR confirmed the total absence of Nodal expression
in all the six samples analyzed, with the expected 366-bp product detected exclusively in the positive control (not shown, figure available
upon request). To further increase the strength of the data, we have performed the same analysis on a second set of seven AML BM speci-
mens, resulting in the exact same outcome (not shown, figure available upon request). GAPDHwas used as internal control to test the good
quality of all the cDNAs used in the experiments (not shown, figure available upon request).
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Abstract
The Grb10-Interacting GYF Protein-2 (GIGYF2) gene has been proposed as the Parkinson-disease (PD) gene underlying the PARK11 locus.
However, association of GIGYF2 with PD has been challenged and a functional validation of GIGYF2 mutations is lacking.
In this frame, we performed a mutational screening of GIGYF2 in an Italian PD cohort. Exons containing known mutations were analyzed
in 552 cases and 552 controls. Thereafter, a subset of 184 familial PD cases and controls were subjected to a full coding-exon screening.
These analyses identified 8 missense variations in 9 individuals (4 cases, 5 controls).
Furthermore, we developed a zebrafish model of gigyf2 deficiency. Abrogation of gigyf2 function in zebrafish embryos did not lead to
a drastic cell loss in diencephalic dopaminergic (DA) neuron clusters, suggesting that gigyf2 is not required for DA neuron differentiation.
Notably, gigyf2 functional abrogation did not increase diencephalic DA neurons susceptibility to the PD-inducing drug MPP+.
These data, together with those recently reported by other groups, suggest that GIGYF2 is unlikely to be the PARK11 gene.
© 2009 Elsevier Inc. All rights reserved.
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1. Introduction
Parkinson disease (PD) is a neurodegenerative disor-
der characterized by the selective and progressive loss of
dopaminergic (DA) neurons in the substantia nigra (SN)
(Olanow et al., 2009). Although only 5–10% of patients have
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a monogenic form of PD, several loci (PARK1–PARK15)
responsible for rare forms of autosomal dominant or reces-
sive PD (Lesage and Brice, 2009) were identified, leading, in
at least 5 cases, to the discovery of the causative gene (SNCA,
parkin, PINK1, DJ1, LRRK2) (Bonifati et al., 2003; Kitada
et al., 1998; Paisán-Ruíz et al., 2004; Polymeropoulos et al.,
1997; Valente et al., 2004).
The PARK11 locus (2q36-37) was initially identified by
a whole-genome linkage analysis in familial PD patients
(Pankratz et al., 2002, 2003a,b). This result was not replicated
in a different PD population (Prestel et al., 2005), however,
the same region was confirmed by a genome-wide associa-
tion study (Maraganore et al., 2005). In addition, a region
overlapping the PARK11 locus was linked to a familial form
of Dementia with Lewy Bodies (Bogaerts et al., 2007).
0197-4580/$ – see front matter © 2009 Elsevier Inc. All rights reserved.
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Recently, GIGYF2 (Grb10-Interacting GYF Protein-2)
was proposed as the PARK11 PD-susceptibility gene (Lautier
et al., 2008). Sequence analysis of the gene (Lautier et al.,
2008) revealed 7 different genetic variants in 12 of 249 unre-
lated familial PD patients from Italy and France; the same
mutations were absent in 227 controls.
Although GIGYF2 represents a good candidate for PD,
given its potential involvement in insulin and insulin-like
growth factor (IGF) signaling (Dufresne and Smith, 2005),
several further studies did not confirm its association with PD
(Bras et al., 2009; Di Fonzo et al., 2009; Guo et al., 2009;
Meeus et al., 2009; Nichols et al., 2009; Sutherland et al.,
2009; Tan et al., 2009; Vilarin˜o-Güell et al., 2009; Zimprich
et al., 2009). Moreover, a functional validation of GIGYF2
mutations is still lacking, mainly because of the toxicity of
the recombinant protein in eukaryotic cells (Giovannone et
al., 2003), and the gene function is unknown.
Besides conventional cellular and animal models,
zebrafish is emerging as a new promising system for study-
ing human neurodegenerative diseases as well as movement
disorders (Anichtchik et al., 2008; Bai et al., 2006; Bretaud
et al., 2007; Flinn et al., 2008, 2009; Panula et al., 2006).
Indeed, the zebrafish DA neuron system has been extensively
characterized, showing that zebrafish ventral diencephalic
DA neurons are functionally homologous to the mammalian
ones in the SN (Rink and Wullimann, 2001). Moreover,
orthologs of most human genes have been found in the
zebrafish genome, including candidates for PD (Anichtchik
et al., 2008; Bai et al., 2006; Bretaud et al., 2007; Flinn et al.,
2009).
In this work, we chose to evaluate the role of GIGYF2
in PD pathogenesis by a combined approach: (1) mutational
screening of the gene in an Italian population comprising 238
familial and 314 sporadic PD patients (selected by the same
institute that collected the cohort analyzed by Lautier et al.,
2008), and an equal number of controls and (2) functional in
vivo analysis of the GIGYF2 ortholog in zebrafish.
2. Materials and methods
2.1. Subjects
We studied 552 subjects with a diagnosis of PD and an
equal number of controls who had contributed samples to
the DNA Bank of the Parkinson Institute, Istituti Clinici
di Perfezionamento, Milan, Italy (“Human genetic bank of
patients affected by Parkinson disease and parkinsonisms”;
http://www.parkinson.it/dnabank.html).
The clinical diagnosis of PD was established according
to the UK Parkinson Disease Society Brain Bank criteria
(Hughes et al., 1992, 2001). The diagnosis of PD required
the presence of bradykinesia and at least one of the follow-
ing: resting tremor, rigidity or postural instability; a positive
response to dopaminergic therapy; absence of atypical fea-
tures or other causes of parkinsonism.
Among the 552 PD patients, 318 were male (57.6%), the
mean age at onset was 55.2 years (range 14–81; SD± 11.42),
and the mean disease duration was 11.08 years (range 3–41;
SD± 6.37). Two hundred and thirty-eight patients were clas-
sified as “familial” having at least one relative among their
1st (142) or 2nd (96) degree family members with a formal
diagnosis of PD. The remaining subjects were classified as
“sporadic” and were selected consecutively from the DNA
Bank. The age at which the patient noticed the first PD symp-
tom was considered to be the age at onset of disease. Presence
of the LRRK2-G2019S missense substitution was analyzed
in all subjects, and 7 patients were carriers of the mutation
(Goldwurm et al., 2006). The parkin gene was analyzed in
all 62 PD patients with onset before or equal to the age of
40 (Sironi et al., 2008). Three patients were found to carry
2 mutations (in the homozygous or compound heterozygous
state). These LRRK2 or parkin mutation carriers were not
excluded from this study.
With the exception of 4 patients, originating from 3 dif-
ferent countries (2 from Argentina, 1 from Albania, and 1
from Greece), all the affected subjects were Caucasian and
of Italian origin.
Controls, unrelated to the patients, were recruited among
spouses and care-givers. Among the 552 controls, 178 were
males (32.2%), the mean age at withdrawal was 63 years
(range 30–84 years, SD± 10). All controls denied any family
history for movement disorders.
The study was approved by the local Ethics Committee.
Each participant signed an informed consent prior to partic-
ipation to the study.
2.2. GIGYF2 mutation analysis
Mutational screening of the GIGYF2 isoform b (Gen-
Bank accession number NM 015575.3) coding region (exons
5–31) was performed by a combination of high-resolution
melting (HRM) analysis (exons 6, 7, 9–13, 15, 18, 20–23,
25, 28, 30, and 31) and direct DNA sequencing (exons 5, 8,
14, 16, 17, 19, 24, 26, 27, and 29).
Genomic DNA extraction was performed from periph-
eral blood using a semi-automatic extractor (QuickGeneDNA
Whole Blood Kit; FUJIFILM Europe GmbH Life Sci-
ence, Düsseldorf, Germany). DNA samples were quantified
spectrophotometrically using a BioPhotometer (Eppendor
AG, Hamburg, Germany), standardized for concentration
(40 ng/!l for the source, 5 ng/!l for the working dilution)
and arrayed into 96-deep-well plates.
Suitable PCR primer couples were designed on the basis
of the known genomic sequence of the gene (GenBank acces-
sion number NT 005403.16.1) to amplify all exons of interest
and their exon–intron boundaries.
For HRM reactions, 7.5 ng of genomic DNA was ampli-
fied in a final volume of 10!l. Reactions were performed
in 384-well LightCycler 480 plates (Roche Applied Sci-
ence, Indianapolis, IN, USA) using the LightCycler 480
HRM Master Mix (Roche). PCR cycling and HRM analysis
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were performed on a LightCycler 480 (Roche). Amplicons
were analyzed with the Gene Scanning Software (Roche).
The sensitivity and specificity of heterozygous single-base
change detection were tested by screening an amplicon (exon
16) containing the known single nucleotide polymorphism
(SNP) rs2305138 with both HRM and direct sequencing. All
heterozygous individuals found by DNA sequencing were
correctly identified also by HRM analysis, confirming the
extremely high sensitivity and specificity of this technique
(Taylor, 2009).
For DNA sequencing, PCRs were performed on 10–20 ng
of genomic DNA in a 25-!l final volume using the Fast-
Start Taq DNA Polymerase (Roche), and following the
manufacturer’s instructions. Direct sequencing of PCR prod-
ucts, purified by means of MultiScreen PCR!96 filter plates
(Millipore, Bedford, MA, USA), was performed by the
fluorescent dideoxy terminator method (BigDye Termina-
tor Cycle Sequencing Ready Reaction Kit v1.1; Applied
Biosystems, Foster City, CA, USA). All reactions were per-
formed using the Mastercycler EPgradient (Eppendorf AG).
Sequencing reactions were purified by the Sequencing Reac-
tion Cleanup Kit Montage SEQ96 (Millipore), and analyzed
by using an ABI-3130XL Genetic Analyzer (Applied Biosys-
tems). The Variant Reporter software was used for mutation
detection (Applied Biosystems).
Primer sequences, as well as the specific PCR conditions
for each primer couple are available on request. Numbering
of mutations is according to cDNA position (GenBank acces-
sion number NM 015575.3), starting from the first nucleotide
of the ATG start codon.
2.3. Animals
Breeding wild-type fish of the AB strain were maintained
at 28 ◦C on a 14 h light/10 h dark cycle. Embryos were col-
lected by natural spawning, staged according to Kimmel
et al. (1995), and raised at 28 ◦C in fish water (Instant
Ocean, 0.1% Methylene Blue) in Petri dishes. Embryonic
ages are expressed in somites (s), and hours post fertilization
(hpf).
2.4. Zebrafish gigyf2 identification and cDNA cloning
The zebrafish chromosome 2 region spanning the
gigyf2 gene was identified through in silico search of the
ENSEMBL zebrafish assembly version 8 (Zv8) using the
human GIGYF2 amino-acid sequence as a bait. Based
on this sequence, 3 gene-specific primers (gigyf2 ATGff:
5′-CAGCACTGTCAGTAAAAGCA, gigy2 ATGff1: 5′-
GAGACTTTCAAGGAAAATGGCG, and gigy2 TGArr:
5′-AAGATCAGCAGCTCTCAAAAGTC) covering the pre-
sumptive start and stop codon regions were designed and used
to amplify the gigyf2 cDNA starting from reverse-transcribed
total RNA purified from 24 hpf embryos. Reaction products
were analyzed by agarose-gel electrophoresis and sequenced.
2.5. Injections
Injections were carried out on 1- to 2-cell stage embryos;
the dye tracer rhodamine dextran was also coinjected. To
repress gigyf2 mRNA translation, an ATG-targeting mor-
pholino (MO) was synthesized (Gene Tools, LLC, Philomath,
OR, USA): 5′-AGTGTCTGGGTTTCCGCCATTTTCC-3′.
The gigyf2 MO was used at the concentration of 2 ng/embryo
and 1.2 ng/embryo in 1×Danieau buffer (pH 7.6) (Nasevicius
and Ekker, 2000). A standard MO oligonucleotide (ctrl MO),
designed against human "-thalassemia, was used as injection
control. Double gigyf2 MO/gigyf2 mRNA injection was per-
formed with 2 ng of MO and 300 pg of synthetic mRNA per
embryo.
2.6. MPP+ (1-methyl-4-phenylpyridinium) exposure
Ctrl MO-injected and gigyf2 morphant embryos were
raised for 24 hpf. At this stage, embryos were manually deco-
rionated and transferred to six-well plates (20 fish per well)
for toxin treatment. Embryos were exposed to a solution
containing 1 mM MPP+ (Sigma, Poole, UK) and harvested
at 48 and 72 hpf for anti-Tyrosine Hydroxylase (anti-TH)-
immunohistochemistry. Control embryos received no toxin.
All experiments were carried out in triplicate.
2.7. In situ hybridization and immunohistochemistry
Whole-mount in situ hybridization (WISH), was car-
ried out as described (Thisse et al., 1993) on embryos
fixed for 2 h in 4% paraformaldehyde (PFA)/phosphate
buffered saline (PBS), then rinsed with PBS-Tween,
dehydrated in 100% methanol and stored at −20 ◦C
until processing for WISH (Jowett and Lettice, 1994).
A 724-bp gigyf2 fragment obtained by RT-PCR using
gyg2 FF (5′-TCTCACTTAAGGTGAGGGC) and gyg2 RR
(5′-GTGATTGGAAGAGCTGATGG) primers was cloned
into the pGemT-Easy vector (Promega, WI, USA). The
recombinant plasmid was linearized by digestion and in vitro
transcribed by T7 and SP6 RNA polymerases for sense and
antisense RNA probe synthesis, respectively, in presence
of digoxigenin-modified nucleotides (Roche). For immuno-
histochemistry, embryos were exposed to rabbit anti-TH
(Chemicon, Temecula, CA, USA), then treated with a biotiny-
lated secondary antibody (Vector Laboratories, Burlingame,
CA, USA). Digital images of all embryos were captured using
a digital camera (Leica, Heerbrugg, Switzerland).
3. Results
3.1. Mutational screening
In order to investigate the frequency of GIGYF2 genetic
variants in familial and sporadic PD cases, a mutational
screening of the gene was performed, using a combination
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of HRM analysis and direct DNA sequencing. Among the 27
analyzed exons, 17 were selected to be pre-screened by HRM
on the basis of the length, presence of known polymorphisms,
and sequence characteristics. Samples with aberrant melt-
ing profiles were then sequenced to identify the underlying
variant.
The study was designed to include 2 phases: in “phase I”,
exons containing previously reported mutations (i.e. exons
6, 8, 12, 13, 15, 18, and 30) were analyzed in 552 cases
(238 familial and 314 sporadic patients), and 552 unrelated
controls. In “phase II”, a subset of 184 familial PD cases and
an equal number of controls were subjected to a full screening
of all 27 coding exons.
After completion of phase I, only 2 of the 7 described
mutations (Lautier et al., 2008) were found, one (N56S, the
most frequently identified across published studies) in a con-
trol individual, and the other (N457T) both in a patient and
in a healthy subject. Moreover, 2 novel nucleotide variations
leading to amino-acid substitutions were found: S273C and
D349E, in 2 PD patients.
After completion of phase II, 3 novel genetic variants were
identified: the A560V and the A1131V substitutions in 2 con-
trol subjects, and the L1209P variation in a PD patient. In
addition, the H1171R variant, found by Lautier et al. (2008)
in a control individual, was detected in a healthy subject.
Summarizing, this screening identified 8 different mis-
sense variations in a total of 9 individuals (4 PD patients and
5 controls) (Table 1).
In addition, 16 synonymous substitutions were found,
including 9 described polymorphisms present in dbSNP
(Table 2). Moreover, the GIGYF2 exon 29 screening revealed
several insertion/deletion polymorphisms. A total of 7 differ-
ent alleles were found, confirming the highly polymorphic
nature of this exon (Table 2).
3.2. Clinical and family studies
The 4 patients (3 females and 1 male) with a missense vari-
ation in GIGYF2 had a typical idiopathic PD. Clinical features
are reported in Table 1. Average age of onset was 55 years and
all patients responded to levodopa and developed dyskinesia
and/or motor fluctuations as the disease progressed. The 5
control carriers of a GIGYF2 missense variant were mostly
females (4 females and 1 male) and well over the mean age
at onset for PD (70 years on average; range: 67–73).
Segregation analysis of the identified missense variations
was possible only in 2 kindreds: in patient PD1529’s fam-
ily the affected relative (brother) was heterozygous for the
S273C mutation, whereas in patient PD274’s family the
proband’s cousin with PD was wild type for the correspond-
ing mutation (N457T) (Fig. 1).
In addition, we were able to test the affected sister of a
proband heterozygous for the V1242I mutation, belonging
to the PD cohort analyzed by Lautier et al. (2008) (reported
with code 848-Z-0079 in the original paper). The proband’s
sister did not carry the missense variant.
3.3. Identification of zebrafish gigyf2
Blast analysis of the ENSEMBL zebrafish assem-
bly version 8 (Zv8) using the human gigyf2 protein
sequence returned 3 positive hits on chromosomes 2, 7,
and 10, respectively. The first one corresponds to the
gigyf2 gene (chromosome 2: nucleotide position 48,388,168-
48,440,688), the other 2 represent different orthologs of the
mammalian GIGYF1, the GIGYF2 paralog. The 4008 base-
long gigyf2 open reading frame (ORF) encodes a putative
protein of 1335 amino acids, which shows 58% of identity
to the human protein. The ORF was amplified by RT-PCR
using forward and reverse primers spanning the regions of
the presumptive start and stop codons.
Comparative genomic analysis revealed a conserved syn-
teny between the chromosome regions hosting human and
zebrafish GIGYF2 (Supplementary Fig. S1).
3.4. Spatio-temporal expression of gigyf2 during
embryogenesis
The spatial and temporal distribution of gigyf2 transcripts
was examined by WISH, with digoxigenin-UTP-labeled
probes (Thisse et al., 1993). The zebrafish gigyf2 transcripts
were detected starting from the 1-cell stage (data not shown),
prior to the onset of zygotic expression (which starts between
2.3 and 5.3 hpf) and are therefore maternally deposited. From
blastula until gastrula stages, gigyf2 mRNA was strongly
detected throughout the blastoderm (Fig. 2A–C). At 28 hpf,
a marked gigyf2 expression in the already defined cen-
tral nervous system (CNS) was detected, whereas a weaker
expression was found in the somites (Fig. 2D). At later
stages of development (48 hpf), gigyf2 expression persisted in
well-defined structures of the CNS as the diencephalon, the
mesencephalon, the cerebellum, and the rhombencephalon
(Fig. 2E), and remained detectable in the somites. The addi-
tional labeling in the notochord (Fig. 2D) may be due to the
extended incubation times with the NBT/BCIP chromogenic
substrate (more than 48 h) required to develop the specific
signal. Indeed, the staining also appears in the control exper-
iment with the sense probe (data not shown).
The early uniformity in expression and subsequent specific
localization of gigyf2 transcript in neuronal tissues is consis-
tent with a possible role of the gene in the development of
the CNS.
3.5. gigyf2-loss-of-function in zebrafish embryos
In order to determine whether gigyf2 is required for the
proper development of diencephalic DA neurons in zebrafish,
the protein level was knocked down by injecting a specific
gigyf2 ATG-targeted MO antisense oligonucleotide. In all the
experiments, gigyf2 MO-injected embryos were compared
to embryos at the same developmental stage injected with a
control MO. The phenotypes observed in gigyf2 MO-injected
embryos were categorized into 3 distinct classes: mild, inter-
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Table 2
GIGFY2 polymorphisms.
Exon Nt changea dbSNP name Aa changeb Aa changec Frequency in
patients (%)
Frequency in
controls (%)
Pd OR (95% CI)
5 c.-4A>C rs11555646 – – 29.3 28.7 0.86 1.03 (0.75–1.42)
6 c.129C>T p.Y43Y p.Y43Y 0.1 0
6 c.162A>G p.K54K p.K54K 0.1 0.1
IVS12 IVS12+98insG rs3217559 – – 1.6 1.4
12 c.906A>T p.S302S p.S324S 0.1 0
15 c.1378C>A rs2289912 p.P460T p.P482T 2.6 2.8
15 c.1419T>A p.P473P p.P494P 0 0.1
16 c.1554G>A rs2305138 p.E518E p.E539E 5.2 4.3 0.36 1.20 (0.61–2.38)
17 c.1716G>T p.A572A p.A593A 1.5 0.5
25 c.2898G>T p.S945S p.S966S 0 0.3
26 c.2940A>G rs3816334 p.Q980Q p.Q1001Q 68.1 71.3 0.34 1.16 (0.85–1.60)
29 c.3629 3631delACA rs10555297 p.Q1211del p.Q1232del 61.5 64.6 0.39 1.14 (0.85–1.54)
29 c.3630A>G rs7563724 p.P1210P p.P1231P 0.3 0.3
29 c.3651G>A rs12328151 p.L1217P p.L1238P 22.4 23.9 0.63 0.92 (0.65–1.30)
29 c.3963 3983del21 p.L1209 Q1215del p.L1230 Q1236del 7.1 6 0.65 1.19 (0.66–2.11)
29 c.3984 3985insGCAGCA p.Q1216 P1217insQQ p.Q1237 1238insQQ 2.1 3.3
29 c.4010 4021del12 p.P1225 Q1228del p.P1246 Q1249del 0.5 0.9
29 c.4009 4021del13 p.P1225TfsX5 p.P1246TfsX5 0.3 0
29 c.3973 3996del24 p.Q1213 Q1220del p.Q1234 Q1241del 0.3 0
29 c.3984 3985insACA p.Q1216 P1217insQ p.Q1237 1238insQ 0.3 0
31 c.3855G>A rs34424361 p.S1285S p.S1306S 0.55 0.86
OR = Odds Ratio; CI = Confidence Interval.
a Numbering according to GenBank accession number NM 015575.3, starting from the first nucleotide of the ATG start codon.
b Numbering according to GIGYF2 isoform b NP 056390.2.
c Numbering according to GIGYF2 isoform a NP 001096617 (for comparison with Bras et al., 2009).
d Allelic association of SNPs with a minor allele frequency greater than 5% was calculated using the Fisher’s exact test (right-tailed).
mediate, and severe (Fig. 3). The mild phenotype (class 1),
consisted of embryos displaying a twist in the terminal part of
the tail (Fig. 3B). The intermediate phenotype (class 2), pre-
sented embryos with defects in the head and eye structures,
encephalic edema, U-shaped somites, and a more twisted
tail (Fig. 3C). The severe phenotype (class 3) consisted of
embryos with a disrupted body pattern, extensive reduction
in the overall body size, and more severe defects in the head
region (Fig. 3D). Such a global effect on zebrafish devel-
opment might complicate distinguishment of the primary
consequences of gigyf2 depletion on DA neurons develop-
ment and maintenance from secondary effects. To address
Fig. 1. Segregation of GIGYF2 variants in pedigrees. The GIGYF2 variant identified in each family is indicated above the pedigree. Numbers under family
member symbols correspond to the best available estimate of current age or the age at death based on information provided by the index cases. Age of onset is
the number adjacent to PD. To maintain the anonymity of the pedigree, the gender of non-affected subjects has not been reported.
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Fig. 2. gigyf2 spatio-temporal expression pattern analyzed by whole-mount in situ hybridization (WISH). (A and B) gigyf2 transcript was detected during
blastula and (C) gastrula stages throughout the blastoderm. (D and E) At 28 and 48 hpf, gigyf2 is expressed in the diencephalon (d), the mesencephalon (m),
the cerebellum (c), the hindbrain (h), and the somites (s). The labeling in the notochord (n) also appears in the control experiment with the sense probe and may
be due to the extended incubation times. Scale bars represent 100!m.
this issue, a lower gigyf2 MO dose (1.2 ng/embryo) was used.
The lower dose produced milder effects in comparison to the
higher one (2 ng/embryo), indicating a dose response to the
gigyf2 MO. Indeed, embryos injected with the lowest MO
concentration had a higher frequency of class 1 phenotype
(70%, n = 100), where the general architecture of the body
axis was comparable to controls, as shown by the expres-
sion of the neural tube marker sonic hedgehog (shh) (see
Supplementary Fig. S2). Only a minor fraction of the injected
embryos showed more severe phenotypes. Therefore, further
experiments were performed using the lower dose, except
where indicated.
Since PD is characterized by a progressive loss of TH-
positive DA neurons, we examined the expression of this
marker in gigyf2 MO embryos by immunohistochemistry.
Abrogation of gigyf2 did not lead to a significant loss of
DA neurons in the diencephalic region of 36 and 72 hpf
embryos (Fig. 4A–D). To further corroborate these data, we
also analyzed the expression of otp1 and prox1, two genes
that were previously shown to be involved in the specification
and differentiation of zebrafish DA diencephalic neurons in
the posterior tuberculum (PT) and in the hypothalamus (Del
Giacco et al., 2006, 2008; Pistocchi et al., 2008). gigyf2 MO
did not determine noteworthy changes either in otp1 or in
prox1 expression patterns (Fig. 4E–H), confirming the lack
of influence of gigyf2 on diencephalic DA neurons develop-
ment. The same results were obtained by using the higher
dose of MO (data not shown).
In order to address whether gigyf2 is involved in the
gastrulation and/or neurulation processes, we analyzed the
Fig. 3. Phenotypical analysis of gigyf2-loss-of-function embryos. (A) 48 hpf-control-injected embryos (ctrl MO) compared to the (B, C, and D) gigyf2 morphants
at the same developmental stage. The phenotypes obtained after the injection of 1.2 ng of gigyf2 MO per embryo were categorized into 3 classes: (B) mild
(long-tail twisted in the terminal part), (C) intermediate (short-tail, head and eye defects, edemas, and U-shaped somites), and (D) severe (disrupted body
pattern, extensive reduction in the overall body size, severe defects in the head region). Scale bar represents 200!m.
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Fig. 4. gigyf2 is not required for diencephalic DA neurons development and
maintenance. (A, B, C, and D) Ventral view, anterior to the top. (E, F, G, and
H) Lateral view, anterior is left and dorsal is up. (B and D) Microinjection
of gigyf2 MO does not affect the number of DA neurons, labeled with the
TH antibody, in the posterior tuberculum and hypothalamus in comparison
to (A and C) ctrl MO-injected embryos at 36 and 72 hpf. (E and F) otp1
and (G and H) prox1 whole-mount in situ hybridization in control- and
gigyf2 MO-injected embryos at 36 hpf. Abrogation of gigyf2 does not modify
the expression patterns of otp1 and prox1. The following abbreviations are
used: posterior tuberculum (pt), hypothalamus (hyp), hindbrain (h), preoptic
area (po), midbrain-hindbrain boundary (mhb), eye (e), liver (li). Scale bars
represent 20!m (A) or 100!m (E).
expression pattern of 2 markers of these critical develop-
mental stages: goosecoid (gsc), essential to establish the
body plan and for the development of the forebrain (Thisse
et al., 1994), and otx2, important in the early specification
of the neuroectoderm (Mori et al., 1994; Simeone, 1998).
The expression domains of otx2 were comparable between
controls and gigyf2 morphants (data not shown), suggesting
that gigyf2 is not involved in the correct specification of the
neuroectoderm. Interestingly, about 10% (n = 50) of gigyf2
MO-injected embryos presented an enlarged gsc expression
domain at the shield stage (see Supplementary Fig. S3),
suggestive of a requirement for gigyf2 function during gas-
trulation. This percentage might represent the small fraction
developing into the most severely affected embryos (classes
2 and 3) reported above.
To demonstrate that embryo alterations were specifically
caused by the MO-induced abrogation of gigyf2 function, we
performed a rescue experiment by coinjecting embryos with
the gigyf2 MO and a synthetic full-length gigyf2 mRNA. In
order to avoid complementarity, the injected gigyf2 mRNA
was transcribed from a cDNA previously mutagenized in
the MO’s recognition site; 80% of the embryos rescued the
normal phenotype (data not shown).
3.6. gigyf2 knockdown does not lead to increased
sensitivity to MPP+
Previous studies revealed that the PD-inducing neurotox-
ins, such as MPP+, can efficiently reduce the number of DA
neurons also in zebrafish (Bretaud et al., 2004; Sallinen et
al., 2009). In addition, MPP+ has been successfully applied
to demonstrate that the knockdown of the zebrafish PD-genes
enhances the susceptibility to neurotoxins (Anichtchik et al.,
2008; Flinn et al., 2009). To evaluate the possibility that
reduced levels of the gigyf2 protein might increase the sen-
sitivity to toxin insults, we exposed gigyf2-knockdown and
control embryos to MPP+. We did not observe any signifi-
cant difference in the reduction of the number of DA neurons
at 48 (data not shown) and 72 hpf (Fig. 5) after exposure to
the neurotoxin, indicating that gigyf2 functional abrogation
does not increase the susceptibility of the DA diencephalic
neurons to MPP+.
4. Discussion
After the nomination of GIGYF2 as the PD-gene under-
lying the PARK11 locus, several studies quickly followed
in the literature (Bras et al., 2009; Di Fonzo et al., 2009;
Guo et al., 2009; Meeus et al., 2009; Nichols et al., 2009;
Sutherland et al., 2009; Tan et al., 2009; Vilarin˜o-Güell et
al., 2009; Zimprich et al., 2009), invariantly challenging the
original positive findings of Lautier et al. (2008). Unfortu-
nately, the majority of these replication studies focused on
sporadic PD patients, notwithstanding the fact that both the
PARK11 locus and the GIGYF2 gene were pointed out by
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Fig. 5. gigyf2 knockdown does not lead to increased sensitivity to MPP+ in zebrafish larvae. Ventral view, anterior to the top in all panels. TH immunohis-
tochemistry revealed that DA neurons of the ventral diencephalon are reduced following MPP+ treatment in comparison to untreated embryos at the same
developmental stage (compare A, MPP+-untreated, to B and C, MPP+-treated embryos). The MPP+-induced loss of DA neurons is not increased following
gigyf2 MO injection (compare B to C). Scale bar represents 20!m.
studying familial PD. Even the work by Nichols et al. (2009),
although describing a full-exon screening in 96 probands
belonging to the original series of families that generated the
linkage to PARK11, did not allow an unbiased comparison
of the frequency of missense mutations in cases vs. controls,
because of the lack of data on healthy subjects. Therefore,
the current genetic data arguing against the involvement
of GIGYF2 mutations in PD pathogenesis are still to be
considered incomplete. Moreover, no experimental studies
have been performed to explore the impact of the identified
GIGYF2 mutations at the protein level.
In this frame, we investigated the involvement of GIGYF2
in PD pathogenesis by a comprehensive mutational screen-
ing in a relatively large Italian population of 184 familial PD
patients and in an equal number of healthy controls. More-
over, exons bearing previously reported missense variants
were analyzed in 368 additional patients (54 familial and
314 sporadic) and controls. Besides representing the largest
GIGYF2 replication study on familial PD, our work has the
additional advantage to have been performed on a cohort of
patients selected by the same clinical centre that collected
the Italian cases studied in the Lautier’s paper (Lautier et al.,
2008).
The combination of phase I (analysis of selected exons)
and phase II (full exons screening) genotyping revealed
a fairly homogeneous distribution of missense variations
between cases and controls (Table 3). In particular, we found
8 different missense substitutions in a total of 9 individuals (4
PD patients and 5 controls). Considering only the 184 patients
with familial PD whose GIGYF2 coding region was fully ana-
lyzed, a mutation rate inconsistent with the one reported by
Lautier et al. (2008) was found (1.6% in cases and 2.2% in
controls vs. 5.7 and 0.8%, respectively).
In 2 out of the 4 carrier patients’ families, we were able
to perform a segregation analysis of the identified missense
variations; in addition, we tested the affected sister of a
proband belonging to the PD cohort reported by Lautier et al.
(2008). Combining our results with those already reported in
the literature (Lautier et al., 2008; Nichols et al., 2009), co-
segregation of GIGYF2 missense variants has been observed
in 7 out of 13 analyzed families. This is equal to what would
be expected by chance.
Table 3
Meta-analysis of GIGYF2 mutation frequencies.
Study Population No. of cases No. of controls Collective frequency of
missense variants
P
Cases (%) Controls (%)
Lautier et al.
Italian 123 131 1.62 0 0.04
French 126 96 0.40 0 0.38
Bras et al.
Portuguese 267 451 0.75 1.66 0.14
North American 460 460 1.09 0.43 0.11
Meeus et al. Belgian 305 360 0.16 0 0.12
This paper Italian 184 184 0.54 0.27 0.56
Combined analysis 1465 1682 0.68 0.59 0.19
OR 1.50, 95% CI 0.81–2.77
The meta-analysis was conducted using allele frequency data from case/control full-exon screenings reported in the literature (Bras et al., 2009; Lautier et al.,
2008; Meeus et al., 2009), including the present study. Non-synonymous variations found in both cases and controls across all the studies were excluded from
the meta-analysis. OR = Odds Ratio; CI = Confidence Interval.
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Pulling together all genetic screenings performed so far
on GIGYF2, a total of 44 missense variations spread on the
entire gene were found. No null alleles, either resulting from
nonsense, frameshift, or splicing defects were described.
Limiting the analysis to case/control whole-coding-region
screenings (Bras et al., 2009; Lautier et al., 2008; Meeus
et al., 2009), including the present work, and excluding the
5 variations found in both cases and controls across all the
studies, the collective frequency of missense substitutions
was comparable between PD patients and healthy individu-
als (0.68% vs. 0.59%, respectively; meta-analysis OR, 1.50;
95% CI, 0.81–2.77; P = 0.19) (Table 3).
Considering that several obstacles hamper a classical in
vitro analysis of the structural and functional consequences
of GIGYF2 missense mutations, the pathogenic impact of
the identified sequence variants was investigated in silico
using the PMut algorithm (Ferrer-Costa et al., 2005). The per-
centage of predicted deleterious mutations calculated by this
software was even lower in cases (50%) compared to controls
(72.7%). Despite the substantial limitations of this in silico
approach, this finding adds to the evidences arguing against
a role of GIGYF2 missense variations in the pathogenesis of
PD.
The most straightforward approach to explore the role of
GIGYF2 in PD, besides genetics, would be to perform func-
tional experiments in cell lines or in vivo. Given the already
mentioned difficulties in setting up a cellular model to study
the function of this gene and its potential implication in neu-
rodegeneration and DA survival, we decided to generate a
vertebrate model of GIGYF2 insufficiency in zebrafish.
Zebrafish gigyf2 is highly homologous to the human
counterpart and its genomic organization is strongly con-
served, as confirmed by the synteny between the chromosome
regions hosting the 2 orthologs in fish and humans. Inter-
estingly, gigyf2 is also expressed in the ventralmost part of
the diencephalon, the region hosting the DA neurons func-
tionally homologous to mammalian SN neurons (Rink and
Wullimann, 2001). These findings prompted us to assess the
potential involvement of gigyf2 in the determination of the
DA phenotype by means of gene function abrogation. The
obtained results indicate that gigyf2 is dispensable for the
proper development of the DA system and its deficiency does
not determine the degeneration of the already differentiated
DA neurons.
As previously demonstrated in zebrafish, the knockdown
of the PD candidate genes PINK1 and parkin increases the
susceptibility to DA neuron loss after exposure to MPP+
(Anichtchik et al., 2008; Flinn et al., 2009). Therefore, we
explored the effects of MPP+ on the differentiation and main-
tenance of diencephalic DA neurons in gigyf2-dysfunctional
embryos. The absence of additional DA neuronal loss in
gigyf2 morphants in a PD-inducing environment suggests that
gigyf2 alterations might not represent a genetic predisposi-
tion to DA neurons vulnerability, a finding of significance in
the ascertainment of the pathogenic role of GIGYF2 in PD
onset.
Taken together, these results strengthen the conclusions
of the mutational screening, which did not evidence any con-
nection of GIGYF2 genetic variations with PD. However,
due to gigyf2 ubiquitous expression in the CNS, we cannot
exclude further roles in neurogenesis. Furthermore, zebrafish
gigyf2 functions might be crucial earlier during development,
as suggested by the generalized and dramatic effects exerted
by higher doses of gigyf2 MO and by the alteration of the
expression pattern of the gastrulation marker gsc. Interest-
ingly, no GIGYF2 nonsense or frameshift mutations have
been identified in this work or by others in humans, sup-
porting the hypothesis that the complete inactivation of the
gene might be incompatible with embryonic development.
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Abstract
Background: The lymphatic vascular system, draining interstitial fluids from most tissues and organs, exerts crucial
functions in several physiological and pathological processes. Lymphatic system development depends on Prox1, the first
marker to be expressed in the endothelial cells of the cardinal vein from where lymph vessels originate. Prox1 ortholog in
the optically clear, easily manipulated zebrafish model has been previously isolated and its contribution to
lymphangiogenesis has been clarified. Because of a round of genome duplication occurred at the base of teleosts
radiation, several zebrafish genes have been retained in duplicate through evolution. We investigated for the presence of
additional prox1 genes and determined their role in zebrafish lymphangiogenesis.
Methodology/Principal Findings: We isolated a second ortholog, named prox1b, and analyzed its expression during
development by whole mount in situ hybridization (WISH). We detected strong prox1b expression in the endothelium of the
posterior cardinal vein (PCV) from where lymphatic precursors originate. To analyze prox1b involvement in
lymphangiogenesis we utilized the fli1:GFP transgenics and followed the formation of the toracic duct (TD), the primary
lymph vessel in fish, after prox1b knockdown. Our findings clearly demonstrated that the absence of prox1b activity severely
hampers the formation of the TD.
Conclusions/Significance: This work provides substantial progress toward the understanding of zebrafish lymphangiogen-
esis. In light of the features shared by the lymphatic systems of zebrafish and higher vertebrates, the establishment of such
lymphatic model will provide a powerful tool to study, for instance, disorders of body fluid homeostasis, inflammation and
cancer metastasis, and may ultimately contribute to novel therapies.
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Introduction
The lymphatic system drains lymph away from tissues and organs
back to the bloodstream, and plays a main role in the immune
response and fat absorption. In addition, the lymphatic system is
implicated in inflammation processes as well as cancer metastasis.
Prox1 homeogene, the vertebrate homolog of prospero in D.
melanogaster [1], regulates cell proliferation, fate determination and
differentiation during embryonic development, and triggers the
molecular program leading to the formation of the lymphatic
system. Indeed, ablation of Prox1 in mouse, Xenopus, and
zebrafish impaired the formation of lymph vessels [2,3,4,5,6,7].
About 350 million years ago, a round of genome duplication
occurred at the base of teleosts radiation resulting in two copies of
all genes. Some of such copies have been retained in duplicate
through evolution [8]. In view of this evidence, we searched for
additional Prox1 orthologs in zebrafish. Interestingly, while we
were conducting the experiments reported in this work, a paper
describing the isolation and the expression patterns of two prox1
genes in the fish medaka has been published [9].
Here, we isolated a second zebrafish ortholog, named prox1b (to
distinguish it from the first identified one, from now on designated
prox1a), and showed that prox1b knockdown impedes the formation
of the toracic duct (TD), the primary fish lymph vessel [10].
Results and Discussion
prox1b cloning and gene structure
Blast analysis of the ENSEMBL zebrafish assembly version 6 (Zv6)
using zebrafish prox1a full-length cDNA sequence returned two
positive hits on chromosome 17, corresponding to the previously
characterized prox1a [11], and prox2 [12] genes, and one hit on
chromosome 7, this last one mapping at chromosome location
19,523,485 – 19,537,485 and never reported before. The 3,558-bp
mRNA sequence is identified by the GenBank accession number
FJ544314 (Figure 1). The encoded protein is related to the prospero
transcription factors family, being characterized by the atypical
homeodomain and two prospero domains, PD1 and PD2 (Figure 1A).
This protein represents the second zebrafish ortholog of Prox1,
producing significant alignments (35% of identity) with all the Prox1
present in the GenBank database, including zebrafish prox1a. prox1b
coding region is interrupted by three introns, and an additional one is
located in the 59UTR (Figure 1A), indicating that the structure of the
gene has been evolutionarily conserved from zebrafish to mammals.
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[12,13]. However, zebrafish prox1b gene does not show synteny with
mammalian Prox1, as for the recently identified medaka prox1b gene
[9]. Analogously to all the vertebrate Prox genes, as well as Drosophila
prospero, prox1b contains the U12-dependent intron (intron 2),
characterized by the unusual AT/AC splice sites, located at the
beginning of the homeobox (Figure 1B) [12,13].
Role of prox1b in zebrafish lymphangiogenesis
Prox1 is a master gene controlling the processes of budding,
migration and proliferation of lymphangioblasts [2,3,4,5,6,7]. In
zebrafish, its contribution to lymphangiogenesis has been demon-
strated by means of prox1a knockdown [4]. In this context, we
examined the possible involvement of prox1b in lymphangiogenesis.
The first signal of gene activity appeared in the central nervous system
(CNS) starting from somitogenesis (10 s stage, Figure 2A), where
prox1b expression persists during development (Figure 2B,C,D,G) (a
more detailed analysis of prox1b mRNA distribution in the nervous
system will be discussed elsewhere). Interestingly, at 48 hours post-
fertilization (hpf), we detected intense prox1b staining at the level of the
posterior cardinal vein (PCV) and of the sprouts emanating from this
Figure 1. Nucleotide and deduced amino acid sequences of zebrafish prox1b. (A) arrowheads show the positions of the introns. The asterisk
indicates the stop codon at the end of the open reading frame. A dotted line marks the polyadenylation site. The wave and solid lines mark PD1 and
PD2, respectively. The homeodomain is boxed. The sequence has been submitted to the GenBank/EMBL database under accession number FJ544314.
(B) prox1b contains the U12-dependent intron (intron 2), characterized by the unusual AT/AC splice sites, located at the beginning of the homeobox.
doi:10.1371/journal.pone.0013170.g001
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vessel into the intersegmental space (Figure 2D,E). The analysis of
transversal sections of hybridized embryos revealed that prox1b is
indeed expressed in the endothelial cells of the vein wall (Figure 2F,
bottom), from where lymphatic precursor emerge to migrate towards
the horizontal myoseptum region. Later on, according to previous
studies, these lymphatic precursors will migrate from the horizontal
myoseptum to a position ventral to the dorsal aorta (DA) and
contribute to the mature TD [4,14]. Notably, we observed the
expression of prox1b on both sides of the trunk, adjacent to the
notochord, at the level of the horizontal myoseptum (Figure 2F, top).
Also interesting, the wall of the DA was not marked by prox1b
expression (Figure 2F, bottom). At 72 hpf prox1b signal was still visible
at the level of the intersomitic boundaries (Figure 2G,H) and the PCV
(Figure 2G,H,I), and appeared in the space comprised between the
DA and the PCV (Figure 2I), where the TD forms starting from
around 3 days post-fertilization (dpf) [4,14]. It is noteworthy that
prox1b medaka ortholog mRNA was not detectable until 3 dpf (34
somite stage) and could be seen exclusively in few territories of the
CNS during development [9].
The pattern of expression of zebrafish prox1b led us to investigate
the possible functional role of the gene in lymphangiogenesis. prox1b
knockdown produced a lymphatic phenotypes that we evaluated
searching for the presence/absence of the TD in fli1:GFP transgenic
fish [15] at 5 dpf (Figure 3), the developmental stage at which the TD
is already fully formed [4,10]. In comparison to control embryos
(Figure 3A,E,I), prox1b knockdown resulted in the absence of the TD
(Figure 3B,F) in 70% of injected embryos (n=70) (Figure 3J).
Interestingly, the lack of the TD determined by the injection of prox1b-
MO was always associated to mild to severe cardiac edema
(Figure 3M,N), resembling the prox1a-lymphatic phenotype previous-
ly described [4]. A small percentage of the injected embryos displayed
impaired circulation, and heart and trunk defects that did not allowed
the observation of the vasculature, and for this reason was not
included in the final analysis. The specificity of the lymphatic
phenotype induced by prox1b knockdown was verified through the
coinjection of a prox1b full-length mRNAproperly mutagenized in the
region targeted by the morpholino, which rescued the normal
phenotype (Fig 3C,G,K). In order to corroborate the role of prox1b in
lymphangiogenesis, the expression of lyve1, a specific molecular
marker for lymphatic endothelial cells [14,16], has been assayed
(Figure 4). In comparison to control embryos (Figure 4A,C), lyve1
expression in the trunk of prox1b morphants was weak or completely
absent at 48 (80%, n=30; Figure 4B) and 72 hpf (82%, n=25;
Figure 4D), indicating an impairment of lymphatic development.
To ascertain whether prox1b might synergize with prox1a to
promote lymphangiogenesis, we coinjected the two orthologs
specific MOs. The simultaneous knockdown of the two genes did
not determine more severe phenotypes or the increase of the
number of affected embryos in comparison to the prox1b-MO single
morphants (data not shown). The attempt to use higher MOs
concentrations resulted in acute generalized defects that impeded
additional analysis of the morphants, as previously reported for the
single prox1a–MO injection [10]. However, it is remarkable to notice
that the prox1b-induced lymphatic phenotype could be rescued by
means of coinjection with prox1amRNA. Indeed, 75% of the double
injected embryos (n= 75) appeared phenotipically normal with a
perfectly formed TD (Figure 3D,H,L), highlighting the evolutionary
conservation between the two orthologs.
Altogether these data support the indispensable role of prox1b in
zebrafish lymphangiogenesis, representing a contribution of basic
importance for the consolidation of zebrafish as a valuable
lymphangiogenic model.
Figure 2. prox1b embryonic expression pattern analyzed by in-situ hybridization. (A) the first prox1b signal appears at 10 somite (s) stage in
the central nervous system (CNS) (black arrowhead). (B) at 24hpf and (C) 36 hpf prox1b expression continues to be restricted to the CNS of the
embryos (black arrowheads). (D) at 48 hpf prox1b mRNA is still detectable in the CNS, and is now expressed in the posterior cardinal vein (PCV) and
the sprouts emanating from this vessel into the intersegmental space (black box). (E) magnification of the region boxed in D; PCV (blue arrowhead)
and vein sprouts (black arrowheads) are indicated. (F) cross sections of 48 hpf-prox1b-hybridized embryos. (F, bottom) prox1b is expressed in the
endothelial cells of the vein wall (blue arrowhead), and not in the dorsal aorta (DA) (red arrowhead). (F, top) prox1b signal is also visible on both sides
of the trunk (black arrowhead), adjacent to the notochord (n). (G) at 72 hpf prox1b expression pattern is comparable to the 48 hpf stage, being the
signal detectable in the CNS (black arrowhead), in the PCV and the sprouts emanating from the PCV (black box). (H) magnification of the region
boxed in G; PCV (blue arrowhead) and vein sprouts (black arrowheads) are indicated. (I) cross section of a 72 hpf-prox1b-hybridized embryo. The
endothelial cells of the PCV are still labelled (blue arrowhead), while the signal is completely absent from the DA territory (red arrowhead). prox1b is
now expressed in the space comprised between the DA and the PCV (arrow), where the TD forms starting from around 72 hpf. y, yolk. Scale bars
represent 100 mm (A,B,C,D,G) or 20 mm (E,F,H,I).
doi:10.1371/journal.pone.0013170.g002
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Methods
Ethics Statement
All embryos were handled according to relevant national and
international guidelines.
Fish and Embryos Maintenance
Fish of the AB strain and transgenics for fli:GFP [15] were
maintained at 28uC on a 14-hr light/10-hr dark cycle. Embryos
were collected by natural spawning and staged according to
Kimmel and colleagues [17].
prox1b identification and cDNA cloning
Zebrafish prox1b gene was identified through in-silico search
using prox1a full-length cDNA as a bait. Two gene specific primers
(prox1bF: 59-CACCGCCATATAACACCACA-39, and prox1bR:
59-TTAACTGCTGGCCCTCCTGT-39) have been used to
amplify the full-length cDNA. The 39 UTR have been obtained
through RACE technique while the 59 UTR has been identified
searching the GenBank ESTs database.
Whole mount in-situ hybridization (WISH)
WISH was carried out as previously described [18,19].
Histological analysis of previously hybridized embryos was carried
out on 8 mm sections.
Figure 3. prox1b depletion results in the complete loss of the thoracic duct. fli1:GFP expression labels the DA (red arrowheads), the PCV (blue
arrowheads), and lymphatic TD (white arrowheads) in 5 dpf embryos. A–D are shown magnified below in E–H. In comparison to control embryos injected
with the stdr-MO (A,E), where 100% of the embryos analyzed displays a normal TD (I), the MO directed against prox1b (B,F) results in the absence of the TD
(asterisks) in 70% of injected embryos (J). (C,G) the specificity of the effect of the prox1b-MO is confirmed by the ability of prox1b mRNA to rescue the
lymphatic phenotype. (K) indeed, MO/mRNA coinjection resulted in about 90% of the embryos showing a normal TD. (D,H) prox1a mRNA is able to rescue
the lymphatic phenotype induced by prox1b-MO injection in about 75% of the embryos analyzed (L). (M) 4 dpf control (stdr-MO) injected embryos
compared to the (N) prox1b morphant (prox1b-MO) at the same developmental stage displaying severe edema (arrowhead). The green box in M indicates
the approximate position of the embryo trunk depicted in A–D. Scale bars represent 40 mm (A,B,C,D), 20 mm (E,F,G,H), or 100 mm (M,N).
doi:10.1371/journal.pone.0013170.g003
Figure 4. The expression of the lymphatic molecular marker
lyve1 is dramatically reduced in prox1b morphants. lyve1 ribop-
robe labels developing lymphatic endothelial cells in 48 (A,B), and 72
(C,D) hpf embryos (all lateral views, anterior to the left; the approximate
region of the embryo trunk imaged in all panels corresponds to the
green box in Figure 3M). In comparison to control embryos injected
with the stdr-MO (A,C), that display a normal expression of lyve1 (white
arrowheads), the MO directed against prox1b (B,D) results in the
absence of lyve1 signal (white asterisks). y, yolk. Scale bar represents
40 mm.
doi:10.1371/journal.pone.0013170.g004
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Injections
Injections were carried out on 1- to 2-cell stage embryos. To
repress prox1b mRNAs translation, an ATG-targeting morpholino
(MO) was synthesized (Gene Tools): 59-GGGAATCCA-
TAGCCTCCTTTTCTGT-39. prox1b-specific MO was used at
the concentration of 6 ng per embryo in 1X Danieau buffer
(pH 7,6). To repress prox1amRNA translation, a prox1a-specific MO
was used at the concentration of 8 ng per embryo, as previously
reported [4,12,20,21]. As control, we injected 8 ng per embryo of a
standard control MO (stdr-MO). MO-mRNA double injection
experiments were conducted using 300 pg of capped mRNA per
embryo together with the above reported amount of the MO of
interest. For live microscopy observation, 5 dpf fli1:GFP transgenic
larvae have been anesthetized and monitored under a fluorescent
microscope. For the in-vivo test of the specificity of prox1b-MO,
300 pg per embryo of the prox1b-GFP sensor plasmid have been
coinjected with 8 ng of prox1b-MO or stdr-MO, respectively (Figure
S1). The presence/absence of the GFP signal has been monitored
under a fluorescent microscope from 24 to 48 hpf.
Supporting Information
Figure S1 prox1b-MO specifically reduces prox1b mRNA
translation. For the in-vivo test of the specificity of prox1b-MO,
a prox1b-GFP sensor has been generated. (A) The construct
contains 96 bp of the 59 UTR, and the first 432 bp of the prox1b
coding sequence (Nprox1b) fused with the GFP open reading
frame. The blue bar indicates the region of the mRNA targeted by
the prox1b-MO. The construct, obtained by PCR, has been
cloned into the pTargeT expression vector (Promega) and used for
injection experiments. (B) GFP-positive cells in the trunk (inset and
arrowheads) and (C) in the yolk epithelium (arrowheads) are visible
following coinjection of the sensor and the stdr-MO. (D) The
complete absence of fusion protein expression when the sensor is
coinjected with prox1b-MO confirms the specificity of action of
the morpholino. Scale bar represents 100 mm.
Found at: doi:10.1371/journal.pone.0013170.s001 (6.42 MB TIF)
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